❌

Normal view

There are new articles available, click to refresh the page.
Today — 18 November 2026Main stream

10 Lessons Learned from Auditing 100 Online Stores

17 November 2026 at 14:57
We audited 100 top online stores and found up to 68% use fake timers, hidden fees, and dark patterns to force sales. The plot twist? These sneaky tricks actually trigger a massive 70% cart abandonment rate and destroy your long-term customer trust.

Study: Menstrual Cycle Irregularities Linked to ADHD, Depression, Anxiety in Girls

18 November 2026 at 02:40

November 17, 2026

Several menstrual cycle characteristics, including timing of menarche, cycle regularity, menstrual pain, and severity of premenstrual symptoms, are associated with more common and severe symptoms of depression, anxiety, and ADHD in adolescent girls, according to a recent study published in European Child & Adolescent Psychiatry.1

The longitudinal study followed 5,673 adolescent girls, ages 9 to 11, over a seven-year period, with annual assessments up to ages 14 to 17.

Premenstrual Symptoms & Menstrual Pain Linked to ADHD Symptoms

Study participants self-reported the severity of premenstrual symptoms, such as irritability and fatigue, and the intensity of period pain (categorized as mild, moderate, or severe). Findings showed that severe menstrual pain was associated with higher anxiety, depression, and ADHD symptoms.

Premenstrual symptoms demonstrated a graded pattern in their association with mental health outcomes. Mild premenstrual symptoms were linked to higher anxiety symptom scores. Moderate premenstrual symptoms were linked to higher anxiety and depression symptom scores. Severe premenstrual symptoms were linked to higher anxiety, depression, and ADHD symptom scores.

The researchers offered several social and biological factors as potential explanations for these results.

“Psychosocially, menstrual pain and [premenstrual symptoms] may result in functional impairment – including missed school, disrupted sleep, reduced social participation – which may contribute to emotional distress,” they wrote.

The Role of Inflammatory and Pain Pathways

The study explained that intense period pain and premenstrual distress may activate inflammatory and pain-sensitivity pathways, increasing vulnerability to anxiety and depression. Researchers also noted that the neurobiological mechanisms for processing pain may overlap with those involved in attention and focus, which could help explain the connection between menstrual pain and ADHD symptoms.

Researchers also suggested that fluctuating estrogen and progesterone may help to explain the connection between severe premenstrual symptoms and higher anxiety, depression, and ADHD symptom scores. These hormones heavily affect serotonin, dopamine, and GABA in the brain. Serotonin is linked to mood; dopamine controls motivation and reward processing; and GABA is crucial for emotional processing and regulation. When hormones fluctuate before a menstrual cycle, these neurotransmitters are impacted too, which, in turn, may influence symptoms of anxiety, depression, and ADHD.

The Lived Experience of Women with ADHD

The relationship between ADHD and hormonal fluctuations is a pressing subject for many ADDitude readers with lived experience. In an ADDitude survey of nearly 2,000 women with ADHD, almost one in two respondents said that hormonal fluctuations had a “life-altering” or “severe” impact on their ADHD.

“I know that the week before my period I am a complete mess,” Addison, an ADDitude reader, said. “I have to prepare for the fact that my world feels like it’s falling apart emotionally, and I hate the way that I look the most that week. These are weeks I often avoid being with people, as I know I am not the most positive and am the most sensitive.”

“I used to have lots of irritability, food cravings, tiredness, and was fuzzy-headed three to four days before my period started,” said Connie, another reader.

“I suffer from symptoms like uncontrolled fits of anger and crying spells and feeling extremely overwhelmed the days before my period. I’m even more moody, irritable and have more trouble concentrating,” said ADDitude reader Elena.

Moreover, women with ADHD are disproportionately affected by premenstrual disorders with more than 40% of women with ADHD experiencing premenstrual dysphoric disorder (PMDD) compared to 3% to 9% of women overall.2, 3 PMDD is also heavily tied to hormonal shifts and mental health.

“PMDD is caused by a high sensitivity to fluctuations in estrogen and progesterone, as well as decreases in serotonin – hormonal changes that happen during the luteal phase of the menstrual cycle,” wrote Dara Abraham, D.O. in an ADDitude article. “During the luteal phase that follows ovulation, estrogen decreases, as do dopamine, serotonin, and eventually progesterone. These changes cause painful and distressing symptoms until the menstruation begins and hormone levels rise again.”

Cycle Regularity and Menarche Linked to Depression & Anxiety Symptoms

The study also found that irregular menstrual cycles were linked to higher depression and anxiety symptom scores. The longer a girl had been having her menstrual cycles, the stronger the link between irregular periods and depression and anxiety symptoms became. Likewise, earlier age at menarche was associated with higher depression symptom scores.

While the study focused specifically on early age at menarche, previous research suggests that early puberty more broadly may have an association to ADHD.

“Researchers are examining why girls with ADHD have about twice the risk for early puberty, and why autistic girls are up to four times more likely to experience early puberty compared to other children,” wrote Molly Nikolas, Ph.D. in an ADDitude article. “In addition to higher rates of obesity and social stress, which could accelerate the onset of puberty, neurodivergent girls may experience differences in dopamine activity, stress response, and immune and neuroendocrine systems — all of which may affect sexual development.”

What This Means for Future Studies & Patient Care

The researchers listed several limitations to the study. Menstrual cycle characteristics were gathered through an annual self-report, and parents reported mental health symptoms. In addition, the relationship between menstrual characteristics and mental health symptoms may be bidirectional. The researchers also reported the associations were modest and that future studies are needed to further explore the potential social and biological mechanisms involved.

The study’s authors said they hope their findings will help healthcare professionals consider menstrual cycle characteristics as potentially meaningful insight when evaluating the mental health of adolescent girls.

Sources

1 Marla, S., Gangaraju, S.H., Nguyen, J. et al. Association between menstrual cycle characteristics and mental health in early adolescence. Eur Child Adolesc Psychiatry 35, 4035–4049 (2026). https://doi.org/10.1007/s00787-026-03163-8 

2 Team, A. E. (2025). PMDD and ADHD: Understanding the connection and managing symptoms. ADDA – Attention Deficit Disorder Association. https://add.org/pmdd-and-adhd/

3 Pooja Thakrar, Kalyani Bhukar, Rajat Oswal, Premenstrual dysphoric disorder: Prevalence, quality of life and disability due to illness among medical and paramedical students. Journal of Affective Disorders Reports, Volume 4, 2021, 100112, ISSN 2666-9153, https://doi.org/10.1016/j.jadr.2021.100112

Before yesterdayMain stream

Spike in ADHD, Autism Diagnoses Driven by Broader Recognition, Understanding

11 November 2026 at 22:45

November 11, 2026

ADHD and autism spectrum disorder (ASD) share overlapping symptoms, and prior studies suggest that nearly half of autistic children also have ADHD.1 Now, two new studies on ADHD and ASD profiles suggest that rising diagnosis rates are a product of improved symptom recognition and diagnostic practices, and that executive function and social impairments seen in both ADHD and ASD may be traced to different cognitive pathways.

The first study, published in JAMA Psychiatry,2 evaluated the health records of 71,000 children and adolescents diagnosed with ADHD or ASD and 713,000 controls; it found that the annual number of individuals in the nationwide Danish health registry with newly diagnosed ADHD and/or ASD increased from 4,944 in 2012 to 9,179 in 2022. The proportion of girls diagnosed with ADHD or ASD and the median age at diagnosis also grew during the 10-year study period from 2012 to 2022.

However, traditional risk factors strongly linked to an ADHD or ASD diagnosis in 2012, such as low birth weight or lower household income, have become progressively less predictive with time. For example, children born with a low birth weight were 54% more likely to receive a subsequent diagnosis of ADHD or ASD in 2012; by 2022, that percentage dropped to 17%. Overall, the study found that children and adolescents diagnosed with ADHD or ASD today more closely resemble their neurotypical peers compared to those diagnosed 10 years ago.

These findings do not mean that ADHD or ASD has become less impairing; the spectrum of cases has shifted as clinicians get better at identifying less obvious cases. Greater awareness of ADHD and ASD, and broader access to diagnostic assessment tools, are also factors contributing to growing diagnoses among children.

“The study results do not show that these conditions are being overdiagnosed, or that they have become less severe,” says Oleguer Plana-Ripoll, Ph.D., a senior author of the study. “Rather, they indicate that the population receiving these diagnoses has changed over time, and this needs to be taken into account when interpreting current trends.”

ADHD and ASD Share Symptoms, Distinct Conditions

The second, smaller study, published in Frontiers in Child and Adolescent Psychiatry,3 found that executive functioning (EF) and social cognition (SC) impairments in children diagnosed with ADHD or ASD may look similar, but the impairments stem from different underlying mechanisms.

The cross-sectional, four-year study analyzed performance-based measures of 123 children, aged 6 to 11 years, across three matched groups: mild ASD, combined-type ADHD, and neurotypical peers.

Findings indicated that both ADHD and ASD groups performed worse than their neurotypical peers on measures of EF and SC. However, children with ADHD demonstrated weak social cognition due to difficulties with response inhibition and attention. Social cognition weaknesses in children with ASD, on the other hand, appeared to result from difficulties in understanding and interpreting social information.

Domains of Greater Impairment in Children with ASD

More specifically, children in the ASD group performed significantly worse than children with ADHD on measures of:

  • Theory of mind: The ability to understand that other people have their own thoughts, feelings, beliefs, and intentions, which may differ from one’s own.
  • Affect recognition: The ability to recognize and interpret emotions in others, including through facial expressions.
  • Cognitive flexibility: The ability to adapt to changes, shift between tasks or ideas, and adjust one’s thinking when circumstances change.

Children with ASD also displayed more difficulties than did children with ADHD on executive function tasks that measured the ability to shift between rules and adapt strategies.

Domains of Greater Impairment in Children with ADHD

Children in the ADHD group performed significantly worse than those in the ASD group on measures of:

  • Response inhibition: The ability to control impulses, resist distractions, and stop an automatic or inappropriate response.
  • Visual attention: The ability to maintain attention to relevant visual information.
  • Auditory attention: The ability to focus on and process relevant information presented verbally or through sound.

How executive functions related to social cognition across disorders was the strongest indication of different cognitive processes between the two clinical groups. In the ADHD group, the theory-of-mind model explained 72% of the variance, compared to just 55% in the ASD group.

The researchers surmise that a person with ADHD relies heavily on executive functions, such as inhibition, auditory attention, and design fluency, for social cognition. In essence, their difficulties in social situations are not because they don’t understand social concepts but because distractions and impulsivity interfere.

In the ASD group, social difficulties were more likely to stem from affect recognition (understanding facial cues) and response set (cognitive flexibility, shifting perspectives), rather than from attention deficit or impulse control.

“ADHD and autism are two separate and distinct conditions that happen to be found together much more frequently than would be expected by chance alone,” says ADHD expert William Dodson, M.D., LF-APA. “For people with co-existing ADHD and ASD, treating the ADHD is a means to an end. The world is a classroom for people with ASD, and they have to be ready to observe and practice what they’ve learned.”

Results from the study suggest individuals would benefit more from targeted ADHD and ASD interventions matched to each disorder-specific profile rather than a single shared approach.

Sources

1Lydia Furman, MD, Children with Both Autism Spectrum Disorder and Attention Deficit Disorder- New Insights (March, 2018). publications.aap.org/journal-blogs/blog/pdfDownload/2377

2Tarp, M.E., Lousdal, M.L., Rask, C.U., et al. (2026). Changes in characteristics associated with ADHD and ASD diagnoses over time. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2026.2722

3Pastorino, G.M.G., Olivieri, M., Aquino, A., Mungo, N., Suriano, R., and Operto, F.F. (2026) Neurocognitive endophenotypes in neurodevelopmental disorders: social cognition and executive functions in children with autism spectrum disorder level 1 and attention-deficit/hyperactivity disorder. Front. Child Adolesc. Psychiatry. https://doi.org/10.3389/frcha.2026.1920753

Using a survey to understand digital design tool usage across the University (as part of the Figma design component library project)

2 November 2026 at 08:24

This year, as part of the Figma component library project, we researched how colleagues across the University use digital design tools in their work. This post explores how we approached the research, from designing and distributing the survey through to analysing the responses and identifying emerging themes. 

In a previous blog post, intern Kaile Liu introduced the wider Figma project, and its aims and objectives: 

What I am working on as a Digital Developer Intern (Figma) 

Request access to the project brief for more details:

Figma project brief

We needed to understand how digital design work happens across the University 

To begin with, we needed to understand how staff across the University design, collaborate and deliver digital work. 

There are a wide range of tools, workflows and practices currently in use. Understanding these existing ways of working would help us explore where Figma fits within the wider digital landscape, rather than looking at Figma in isolation. It also supports the work we are doing to improve our Figma component design library.

To hear from colleagues across a wide range of roles and disciplines, we chose a survey as the main method for this research.

Five questions framed our research 

As well as understanding what tools people use, we wanted to find out how those tools support their work and where there may be opportunities to improve existing ways of working.  

Our research was underpinned by five key questions: 

  • What tools are people using day-to-day? 
  • How do those tools support their work? 
  • Where do people experience challenges or inefficiencies? 
  • How do teams collaborate when creating digital content and services? 
  • Where are there opportunities to provide better support, guidance and training? 

These questions helped us build a broader picture of digital working practices across the University. Additionally, working this way allowed us to look beyond any individual or singular tool.

Hearing from more than just traditional design roles was important 

Design work happens across many different roles at the University, including roles not traditionally associated with design or that do not have ‘design’ in the job title. For example, a communications officer creating digital content, a developer sketching a wireframe, a UX practitioner co-creating a prototype or a learning technologist building online resources may all be making design decisions as part of their work. 

This meant looking beyond traditional design roles and hearing from colleagues who use digital design tools in different ways.  

Initial conversations helped us shape the research 

Before designing the survey, we carried out an initial set of user interviews with staff from across the University. We also drew on existing University communities and communities of practice to understand the different roles involved in digital design work. These conversations gave us an early view of how colleagues use and collaborate through digital tools. They helped us identify the groups we wanted to hear from and shape the questions we wanted to ask in the survey.

Adapting our survey to broaden our understanding of ways of working

Based on these interviews, we recognised that a single set of questions would not capture the differences between roles particularly well. Instead, we adapted the survey so that respondents would answer shared questions and then be filtered to questions relevant to their role and ways of working.

This, in essence, would give us a more consistent set of responses while still allowing us to explore some of the differences between roles.

Role categories allowed us to tailor the survey 

We created a filter with seven options: 

  • Marketing and Communications 
  • UX and Human-centred Design 
  • Graphic and UI Design 
  • Developer 
  • Project or product manager 
  • Research 
  • Other (for participants who did not feel represented by the other groups) 

Participants selected the options that best reflected their work, determining which role-specific questions they were shown. They also provided their job title.

The survey combined common and role-specific questions 

The survey consisted of three main sections. The questions included a mixture of multiple-choice and open-ended responses. This allowed us to identify broader patterns while also giving colleagues opportunities to explain their experiences in more detail. 

The opening section included five common questions about participants’ roles, the types of digital design work they do and the tools they use, including tools for collaboration, diagramming and presentations. 

The middle section included around four to six role-specific questions, depending on the participant’s selected group. These explored aspects of digital working relevant to each group. For example, marketing and communications colleagues were asked about the tools they use when designing marketing materials, while developers were asked about the tools and approaches they use during the design phase of projects. 

The closing section included 15 common questions focused on colleagues’ experiences and expectations of digital design tools, including Figma. We asked which tools colleagues would be likely to use, whether they experienced challenges with their current tools and how their work might be affected if they lost access to Figma. 

We wanted the survey to reach as many colleagues as possible

We distributed the survey primarily through existing Teams channels and University communities, which helped us reach a wide range of roles. These included groups focused on marketing and communications, human-centred design and digital development, as well as distribution via heads of IT. 

The survey received 55 responses  

We heard from 55 staff across a range of roles. Based on the categories participants selected when completing the survey, these were as follows: 

  • Marketing and Communications: 20 
  • Developers: 10 
  • UX and Human-Centred Design: 6 
  • Graphic and UI Design: 3 
  • Project or product manager: 2 
  • Other: 14 

Although seven categories were available in the survey, no participants selected ‘Research’ as their primary category, so it is not shown in the breakdown. 

The ‘Other’ category included colleagues working in areas such as product and project management, learning technology and academic support. 

We refined the groups when analysing the responses 

The survey categories gave us a useful starting point, but participants did not always recognise themselves within the roles specified (even when their job title directly reflected one of the options). For example, a participant selected themselves as ‘Other’, but their job title indicated that their work was within graphic design.

In order to evaluate the responses effectively, we revisited participants’ selected categories alongside their job titles and descriptions of their work.

This helped us six create groups that gave us a more useful basis for comparing responses:

  • Developers and technical specialists 
  • UX practitioners 
  • UI and graphic designers 
  • Marketing and communications staff 
  • Product and project managers 
  • Learning technology and academic support staff 

Some of these groups needed to be created on the back of this, as we had not identified those specific roles. For example, Learning Technologist was not an option for participants to select, but emerged as a useful category based on the number of respondents who had this as their job title. 

After this assessment, we were in a better place to begin analysis, as these groups gave us a more useful basis for comparing responses while still reflecting the range of roles represented.

Analysing the survey results required two approaches 

The survey produced both quantitative and qualitative responses, and we used different approaches depending on the type of question and response. 

For the role-specific questions, we used FigJam (Figma’s whiteboard for online collaboration) to review and compare responses across the different groups. This included both quantitative and qualitative responses, allowing us to look at the detail within each role as well as compare responses across the wider dataset. We used Power BI, a data visualisation platform, to explore the common quantitative questions, which gave us a consistent set of responses across all participants. 

We used FigJam to explore the role-specific responses 

We created a large collaborative FigJam board to organise the responses. FigJam supported discussion within the project team, allowing us to work in tandem and analyse the data as a group (in person and asynchronously).

We read through responses from each group, compared them across different roles, and identified recurring patterns and themes. FigJam also allowed us to consider the quantitative responses alongside the more detailed qualitative answers, giving us a fuller picture of ways of working. 

Screenshot of three frames on FigJam full of stickies. There is a blue section, titled Developers, an orange section titled Marketing and Communications, and a green section titled Graphic visual and UI design.

Section of our analysis on the FigJam board

Power BI helped us explore the common quantitative responses 

Power BI allowed us to visualise responses across the opening and closing questions. We wanted to do this as they were common questions asked of all participants. Power BI allowed us to bring our data to life by presenting the data in a more visual way, highlighting the common patterns and themes more easily.

Screenshot of Power BI visualisations. There are seven individual bar graphs of different colours, alongside a larger bar graph with these seven combined. The large bar graph has a right skewed narrow tail. There are also two sets of pie charts, each consistening of seven smaller charts and one larger combined. The data itself is not visible.

Section of our Power BI visualisations for the project.

Grouping responses helped us identify recurring themes 

The open-ended questions in the role specific sections had more detailed responses. This required us to compare responses across the different role groups and group similar comments together to identify recurring themes. 

As we worked through the responses, we also noted areas where a follow-up conversation with a participant could provide more context.

We also captured key quotations that illustrated what participants were telling us in their own words. These will be useful for when we playback findings to colleagues and complete a written report. 

The research will inform the next stage of the project 

The research highlighted both the diversity of digital working practices across the University and common themes across different roles. 

The next stage will bring these findings together into a report. It will highlight where Figma currently supports existing workflows and where its integration will provide more consistent, unified delivery of digital practices across the University.

Testing with users informed the Institute for Academic Development’s content migration

28 October 2026 at 16:27

The User Experience Service worked with colleagues from the Institute for Academic Development to test their content with users. Results from the testing supported content decisions in migration work that these colleagues carried out later in the summer.

This is part two of a two-part series. Part one is available here:

How we helped the Institute for Academic Development to establish user needs for their website

We had established some user needs but wanted to learn more

In two online sessions, we had worked with Institute for Academic Development (IAD) staff to establish a shared understanding of what users needed from their service.

We now wanted to find out about the experience of students who use the IAD website. Specifically, we were interested in two audience groups:

  • Postgraduate research (PGR) students
  • Students from all stages who might need academic skills support

Along with tests on the existing site, we also wanted to try out some new layout ideas and learn about what types of content these audiences would find most useful.

An in-person event gave us an opportunity to hear from PGR students

We knew that presenting information about workshops would be a priority for the new sites and we wanted to know the best way to present this. To inform the design, we needed to speak to people who might use the website to look for these workshops.

Fortunately, the perfect opportunity was just coming up. On 17 June, a large group of research students would be attending PhD Horizons, an all-day careers event at McEwan Hall. We planned two simple research tasks that we could carry out on the day. Emma Horrell and I attended the event with UX team interns Hannah Watson and Shlok Gupta. This was a great opportunity for Hannah and Shlok to gain hands-on experience of in-person UX research.

Usability testing helped us to learn about the existing site

The first task was a quickfire usability test asking PhD students to use the IAD website. For the testing, we handed PhD students an iPad and presented them with two scenarios:

  • Imagine your viva is coming up. How would you find a workshop to help you prepare for this?
  • You’re going to a conference and want to get better at presenting. What can you find on this site that could help you to do this?

Paper prototyping gave us insight into alternative designs

For the second task, we presented four paper prototypes of potential homepages for postgraduate researchers. PhD students compared the prototypes and talked about which areas of the site they would find most useful. This gave us an indication of how closely these homepages aligned with their needs, and it also provided insight into how the language used in the prototypes might be understood.

Clipboards and sticky dots on a table.

We used paper prototypes of homepages to test ideas with students.

A piece of A4 paper with a rough mockup of a webpage. Page is titled Support for postgraduate researchers. There are 4 boxes with titles Explore our workshops and courses, Plan your PhD journey, Browse our writing support courses, and Not sure what training you need? Launch the Development Needs Analysis tool. There are sticky dots on the page.

Students used sticky dots to indicate which areas of the paper prototype would be most useful to them.

What we learned from the usability testing and paper prototyping

In the end, we heard from about 20 PhD students who told us how they might search for workshops on the IAD website. From these conversations, we learned how these students responded to items presented on the live site and what they thought of some potential alternative ideas.

In the usability testing activity, we learned which ways of presenting workshops were perceived as being more useful than others. For example, most participants did not use the embedded PDF brochure, despite it being prominently located on the PGR landing page. Instead, we saw users gravitate to webpages showing workshops grouped by theme, or as an A to Z list.

Screenshot of the Postgraduate Researchers page on the Institute for Academic Development website. An embedded brochure is at the top of the page.

Users did not interact with the embedded PDF brochure.

Observations like this gave us a steer on which categories and methods of presenting workshops would be most useful to PGR students in future designs of this content.

In the homepage paper prototype activity, one of our mock-ups included an option to complete a Development Needs Analysis. This is a form that new PGR students can complete to assess their learning needs. But when we presented the text ‘Development Needs Analysis’ in our prototype homepages, most students could not guess what this was. That seemed like something that could be addressed in the new website.

We shared the findings with colleagues tasked with developing the new site for postgraduate researchers.

We ran usability tests on the academic skills content

Alongside this work, we were helping IAD staff to develop content for a new academic skills website. We agreed that a short round of usability testing on the existing IAD site would help us to get a better understanding of what it’s like to use it. We wrote a script for a 15-minute test and recruited four students working on summer internships at the University. A week later, we were on a Teams call with those students, watching them use the site.

The tasks we set in the usability tests were as follows:

  • You’re an undergraduate student at the University of Edinburgh. You’ve just started a new course. You’ve got your reading list, and you’re feeling overwhelmed by it. Your student advisor has said to book a one-to-one meeting with the Institute for Academic Development (IAD). You land on the IAD website homepage. Can you find out how to book a one-to-one?
  • You’re a postgraduate taught student. You’ve seen a poster advertising dissertation workshops. You arrive at the IAD homepage. Can you find a workshop that will help you with writing your dissertation?
  • You’ve just completed your first year of your History degree. Your exams didn’t go so well and you have a resit coming up in August. Your friend said there’s some advice on preparing for exams on the IAD site. Starting from the homepage, can you show me what advice you can find?

What we learned from testing the academic skills content

None of the participants clicked on the Study Hub resources. The Study Hub contains valuable content that could help students with the problems we presented in the test. But none of the participants followed links to the Study Hub, despite these links being present on several of the pages that participants used.

The Exam Bootcamp page did not lead participants to other exam content. When looking for support for exams, participants scanned the homepage for any mention of exams. This led them a page about Exam Bootcamp, a resource available on the Learn VLE. Participants seemed pleased to find this but didn’t find any of the other available resources or workshops about exams.

Participants did not seem phased by the amount of dissertation workshops on offer. When tasked with finding a workshop to help with dissertations, participants reached a page that listed 17 different workshops on the topic of dissertations. We had anticipated that that might be a problem. But none of the participants seemed worried about how they would choose a workshop to attend. They scanned through the list and picked those that looked like they might be relevant.

The new sites are now live

The teams working on the new sites took the findings from the strategy sessions and the user research and fed this into the development of four new sites. The new sites went live in July, using layout, wording and information architecture choices that reflect some of the insights gained from the content review work.

For example, the Postgraduate Researcher and Career Development site puts PGR workshops in a prominent location on the homepage. Users can browse all workshops, or view them grouped by theme. Next to that, a card shows development support options for PGR students at different stages of their studies (‘Starting out’, ‘Keeping on track’ and ‘Final stage’), echoing the variation between needs at different stages that we identified in the content review.

Postgraduate Researcher and Career Development

Screenshot of the Postgraduate Researcher and Career Development homepage. There are cards on the homepage reading Explore our PGR workshops, Find development for every stage, and Not sure what training you need?

In a similar way, the new Academic Skills homepage leads with the priority content we identified in the review. Study Hub is given the most prominent location at the top left of the screen on desktop, and at the top of the screen on mobile. Cards for workshops and one-to-one meetings show the support services that are available to students. Elsewhere on the page, students can find support for topics such as writing, making notes, literature reviews and exam preparation.

Academic Skills

Screenshot of the Academic Skills homepage. Cards on the homepage are titled Visit Study Hub, Browse our workshops, and Book a one-to-one.

Reflections on this work

This work was a great example of how you can take an evidence-informed approach to content strategy when you’re working to a tight deadline. It also showed how you can use a website migration as an opportunity to review the content you have and think about how it supports your service. By drawing on existing knowledge about users, and testing ideas and prototypes with them, the teams were able to make decisions about their new websites with user needs in mind.

If you’re reviewing your content

If you’re thinking about reworking what you have on your website, get in touch. The User Experience Service can help you to evaluate what you have, develop your content strategy and bring user research into the process.

Contact the User Experience Service

How we helped the Institute for Academic Development to establish user needs for their website

28 October 2026 at 16:26

This summer, the User Experience Service worked with colleagues from the Institute for Academic Development to review their content ahead of a website restructure. In this post, we look at how we developed a shared understanding of user needs to help guide this work.

Supporting the migration of IAD content

At the end of the academic year 2025 to 2026, the services performed by the Institute for Academic Development (IAD) moved to different areas of the University. As part of this change, the IAD website was being shut down.

Content from the IAD website was moving to four new sites:

In June 2026, there were 900 published pages on the IAD website. Time was tight, with the content needing to have moved to its new location by August.

Members of the User Experience Service (Emma Horrell, myself, and interns Hannah Watson and Shlok Gupta) worked with colleagues from the IAD to prepare for this move. In this post, I’ll outline how we worked together to establish who uses the content and what user needs it supports.

We ran two online sessions to identify service users and their tasks

In a content review, we typically start by working out who’s using the site and what they’re trying to do when they arrive at it. It’s also useful to know what kind of events trigger people to visit the site and what information is likely to be most valuable to them at that point.

To answer these questions, Emma Horrell and I ran two online sessions with colleagues who were familiar with the existing content and who would be involved in creating the new sites. We wanted to draw together existing knowledge about users of the IAD’s services so we could establish what these users need from the IAD website. Each online session brought together a small group of specialist staff. We met over Teams and used Miro to gather the information.

Session 1: Postgraduate research students

In the first session, we focused on content for postgraduate research (PGR) students. Through discussion, it became clear that this audience group has shifting needs as they complete their programme of study.

We grouped the student needs on Miro and three stages became evident:

  1. They become a PGR student
  2. They get started with their PGR programme
  3. Later in the programme
Screenshot of Miro showing three circles with sticky notes in each one. Text on the sticky notes is too small to read.

We collected user needs and grouped them into three stages.

New PGR students have distinct needs

We learned that new PGR students might hear about the University’s academic development services in Welcome Week or in a conversation with their supervisor.

At this early stage in their programme, their tasks might include:

  • find workshops that are relevant to me
  • sign up for newsletters that tell me about future workshops
  • learn what I can expect from my upcoming programme of study
  • connect with other PGR students at the University of Edinburgh

PGR student needs change as they progress in their studies

Later in their PhD, these same students will likely have different needs. For example, they might be looking for a particular workshop that will help them to:

  • write a dissertation
  • put together a literature review
  • prepare for a viva

They might also be thinking about what comes after their PhD and what they need to do when they take the next steps in their career.

Some tasks apply at all stages of a PGR student journey

At all stages, PGR students could have these needs:

  • find out which services support academic skills development
  • find out what these services do
  • engage with these services in the event of questions
  • find out what’s on (workshops, support sessions)
  • get updates about upcoming workshops (for example through a newsletter)
  • access policy and standards information

At times, PGR students may also need to know about other University services that can support them. For example, Edinburgh Research Office and Edinburgh Innovations can provide support with funding applications. The Student Counselling Service can support with health and wellbeing issues.

Presenting available workshops was the priority

Our discussions made it clear that presenting information about workshops was going to be the top priority on the new site for PGR students. On the IAD website, workshops were presented in a variety of ways:

  • in an A to Z list
  • listed by theme
  • on a page called “At a glance – workshops this month”
  • in an embedded PDF brochure

Session 2: Users of academic skills content

Alongside this work, other IAD staff were preparing content for the new academic skills site. This would have a different purpose to the site for PGR students, and it would be pitched at a wider audience of students at all stages of study.

An online session helped us to understand user needs

We ran a second session with a small group of IAD colleagues to learn about the existing academic skills content. Specifically, we wanted to know:

  • who uses academic skills content
  • how they arrive at it
  • what they need from it

As in the first session on postgraduate research students, we gathered together known user needs and looked for common themes.

Screenshot of sticky notes on a Miro board. Groups of sticky notes are titled Writing, Workshops, AI, How to get in touch, Exams, Wellbeing, Finding literature and Planning and organising time.

We used Miro to collect the needs of students looking for academic skills support.

Through these discussions, we developed some scenarios to illustrate how a student might arrive at the site. For example:

An undergraduate student gets a poor grade for an assignment. They speak to their student adviser about how to improve their essay-writing skills. The adviser directs them to the IAD. The student goes on the IAD website to look for resources or workshops about essay-writing.

By thinking about user tasks in this way, we developed our understanding of what it might be like to be a student scanning the homepage, looking for content that will help them to complete the task they have in mind.

We also established that the priority for the new academic skills website would be content that supports the following:

  • Booking on a one-to-one study skills consultation session.
  • Finding a study skills workshop.
  • Finding online resources to support study skills such as writing and presenting.

Understanding student users and their priority content like this gave us a foundation for what we needed to do to assess the site and consider alternative designs.

The sessions uncovered a need for testing

Through these two sessions, we collected existing understanding of who was using the IAD website and what they needed from it.

This led us to the next stage of this work. We wanted to know what it was like for these users when they interacted with the site. Could they find what they were looking for? What might be the best way of organising this content on the new sites?

To answer these questions, we carried out two sets of user research:

  1. To support the work developing content for PGR students, we joined a Careers Service event at McEwan Hall to hear directly from those students, seeing how they responded to existing pages and some prototyped alternatives.
  2. To support the work developing academic skills content, we ran a short series of usability tests to observe students using the existing IAD website.

Read more about this work

This is part one of a two-part series. In the next post, I’ll explain how we used paper prototypes and usability testing to learn how users interacted with various site layouts.

Testing with users informed the Institute for Academic Development’s content migration

Architecting a new website to support dementia research at the University

23 October 2026 at 12:32

Alzheimer’s and dementia research is a flagship strength of the University.  Websites of different research units play a key role in supporting this work. The UX Service worked with the Alzheimer Scotland Dementia Research Centre to design and launch Dementia.ed, a new home for dementia research at the University.

The University of Edinburgh is internationally recognised for research on dementia and Alzheimer’s, with different research activities occurring across groups, labs, centres in and across the various Colleges. The team at the Alzheimer Scotland Dementia Research Centre had identified a need to join up different research activities, to ensure connections could be made across different research initiatives by facilitating an interdisciplinary University network.

A website was the proposed way to meet this need, with the intention that this site would provide visibility of the different research areas, to enable academic researchers to exchange knowledge and expertise within the wider dementia and ageing research community. The site was also anticipated to have a secondary, non-academic audience: people with a general interest in learning about and supporting dementia research.

With the go-ahead to build an EdWeb2 site confirmed, Angel Garmpi from the ASDRC contacted the UX Service for help to shape the new site.

Before creating a site, we thought through a content strategy

In the seminal textbook on content strategy, ‘Content strategy for the web’ by Kristina Halvorsen and Melissa Rach, the authors introduce content strategy as a way to avoid being tormented by a burden of excess content to be managed. Starting a site from scratch is a golden opportunity to make decisions upfront to prevent content spiralling out of control, leading to website bloat and content debt further down the line.

The framework in the book outlines four elements of content strategy:

  1. Substance – what content does the site need and why?
  2. Workflow – how does the content get created and maintained?
  3. Governance – who owns the site and is responsible for its content?
  4. Structure – how should the content be organised so it can be found?

These elements served as a useful way to tease out key considerations from the start, setting a path for good decision-making and planning for the longer-term, past the website launch.

Substance: Content for dementia researchers and for people interested in dementia research

By considering questions about what the site was for, and who would visit the site and why, we were able to establish the site substance.

The ASDRC team had identified five main purposes for the site:

  1. To facilitate a network where researchers could come to collaborate with others on research work
  2. To showcase and bring together the different groups, centres and parties involved with and supporting dementia research
  3. To be a source of information where people interested in dementia research could come to read about latest insights
  4. To serve as a volunteer hub to capture details of people wishing to participate in dementia research (or make tissue donations)
  5. To act as a payment portal where supporters of dementia research could make financial donations.

Using these purposes as a starting point, we defined primary and secondary site audiences and their associated tasks to flesh out detail of the site substance.

Site audience 1 (primary): Academic researchers working on dementia and ageing

Needs and tasks:

  • Meeting other researchers and groups working in related fields
  • Establishing peers to collaborate with and exchange knowledge
  • Getting support and help with grant and funding applications

Content to support:

  • Contact details of the different groups
  • An entry point to join the network
  • Ways/touchpoints to stay informed such as events

Site audience 2 (secondary): People interested in tracking dementia research developments

Needs and tasks:

  • Finding out about dementia research in relation to a specific condition of interest
  • Staying up-to-date with advances in specific areas of dementia and/or ageing research
  • Identifying relevant academic papers and publications to form the basis of journalistic content

Content to support:

  • Publications and updates about dementia research
  • News articles about topical research areas

Site audience 3 (secondary): People wishing to take part in dementia research

Needs and tasks:

  • Registering to donate brain tissue
  • Volunteering to participate in academic research studies

Content to support:

  • A place to register interest in becoming a research participant

Site audience 4 (secondary): People wishing to make monetary donations

Needs and tasks:

  • Donating money to contribute to the progress of dementia or ageing research

Content to support:

  • A portal where financial donations can be made

Workflow: content is curated and published by the ASDRC

Considering the site substance led us to think about where this content would come from – the sources and the subject matter experts behind it. All too often, websites are built and filled with content for a launch, but without mapping out the content sources and understanding the underlying creation processes, launch-day content is at risk of quickly going stale because there is no plan in place to maintain it.

To fulfil its primary purpose of facilitating dementia research networks, the bulk of the content for the Dementia.ed site was planned to come from the different University-wide dementia research groups and initiatives. This content would be captured as links to the different sources, to ensure it was current. Events from the different groups needed to be highlighted as network-forming opportunities, so these were planned to be pulled together in a single location on the Dementia.ed site by the ASDRC team. It was also felt that the site should provide a round-up of news from different areas, which again would be curated by the ASDRC team.  Finally, the site would include static content such as: practical information about the ASDRC and the dementia research network, contact details, information about how to join the network and details for how to contribute, either donations or by participating in a study.

Taken together, this meant the initial content-related work requirement from the ASDRC team would be: to create the static content for the site in the different sections and to establish the correct links for the different research groups. Going forward, there would be a maintenance required to check the static content and the links remained correct, and to produce events and news content, which all  seemed doable given resource in the ASDRC team.

Governance: ASDRC team owns the site and manages the content

Considerations of how the new site would be governed were related to the workflow processes. A prerequisite for obtaining an EdWeb2 site is the need for a named site owner to take overall responsibility for the site, and the same ASDRC team member responsible for creating, curating and maintaining the site content had been assigned the role of site owner. This kept things straightforward in terms of decision-making about the site’s content and overall direction, although there was a need for the site owner to forward-plan a content calendar for maintenance, curation and creation tasks, and to assign responsibility to other ASDRC team members as a back-up to avoid a single point of dependency.

Structure: content arranged under common user tasks

Starting the design of a new website from a blank canvas can be difficult as there are lots of questions to consider at once. What should the menu contain? What should be on the top of the homepage? How should the content link together?

Another core textbook useful in site building is ‘Information Architecture’ by Peter Morville and Jose Arango. In this book, the authors encourage thinking about how to group or categorise content (in an organisation scheme) as well as how to establish relationships between those groups or categories (in the organisation structure).

Typically, websites adopt ambiguous organisation schemes – with content arranged by topic, subject, audiences and/or tasks to encourage browsing and discovery. This approach was appropriate for the Dementia.ed site to enable it to support the different audience groups and their associated needs and areas of interest. We considered a task

For the organisation structure – a non-hierarchical flat arrangement made most sense. Given the site was anticipated to have a relatively small number of pages, and would have clear calls-to-action for the different audiences, it didn’t seem necessary to plan a heavily hierarchical structure. For the content in the different research group sites, a hub-and-spoke model could be adopted, with Dementia.ed acting as the central hub, linking off to the different sources.

Before building, we needed to sense check the proposed site map with users

With ideas for the site mapped out, it was tempting to just get building in EdWeb2. Before creating the new site, it was wise to test assumptions with some testing.

Usability testing – where audiences are given a task to perform online and are observed as they do it – always provides an excellent source of insight into how audiences naturally interact with a digital artefact like a website, how they make sense of the menu labels and use on-page content elements to find their way to complete their tasks.

When it comes to new sites, however, it can be difficult to know what to test with users. If you mock-up a prototype, which parts should you include and which can you omit? Asking participants to make sense of menu labels that lead to empty pages can feel unnatural, and setting participants tasks can fall flat if there’s no real-life site content where they can find the information they need to complete tasks authentically. All that said, it’s impractical to build out an entire site just for testing purposes, as it’s likely the testing will reveal ways it needs to change which can end up adding more work.

We used another research network site as a proxy to test with

Thinking through the options with the ASDRC team, we came up with a plan. The ASDRC team had started looking at other research network sites for inspiration and ideas about how to build Dementia.ed, so we decided to adopt one of these sites for the basis of a test.

We chose the Edinburgh Mental Health Network (EMHN) as a testing site. This site included top level menu items: People, Research, News, Events, Blog and Contact. It had a total of 13 main pages with additional pages within the News, Events and Blog sections.

Access the Edinburgh Mental Health Network website

Since the site supported researchers in mental health as well as audiences with a more general interest in the topic, we were able to shape a usability testing protocol to use the site to assess how two audience types sought to complete representative tasks:

Audience 1: Academic researcher wanting to join the research network

Representative tasks:

  1. Find out what the network is, and its goals and values
  2. Find out how to become part of the network and what this would entail
  3. Find out about upcoming activities
  4. Find research opportunities in the network
  5. Find out how to develop your research project and involve people with lived experience
  6. Find content you can use in support of a funding application

Audience 2: Non-academic with a personal interest in the research area

Representative tasks:

  1. Find out what research is being done across the network
  2. Find out how the network is managed
  3. Find out how to keep up with what’s happening in the network
  4. Find out how you can contribute as a research participant for studies
  5. Find out how to donate money to support the research

Some of the tasks mapped clearly to specific sections of the EMHN site, whereas others were more ambiguous – they could have been completed in multiple sections. In all cases, it was useful to see how participants approached the tasks, so we could use their expectations to design Dementia.ed in the most audience-focused way possible.

We learned which menu labels worked, and which didn’t

The results of the testing gave us a clear steer on which elements of the Edinburgh Mental Health Network site supported the different user groups completing their tasks and therefore would be a good fit to adopt in the new Dementia.ed site. The tests also showed areas where the approach of the EMHN site was lacking – and therefore where different structuring and/or labelling was more appropriate.

The Events and News sections worked well

To complete tasks about finding out about activities and keeping up with what was happening, participants naturally gravitated towards the Events and News sections of the EMHN site, where their expectations of finding events to sign up to and articles to read were met.

The EMHN site was lacking a specific place for information about the network

When working on tasks geared at finding out what the network was, what its goals and values were, and detail about how the network was run, participants looked for an ‘About’ section when they used the EHMN site. When they realised this didn’t exist, they tried multiple other locations including the homepage and the Research section. This suggested an ‘About us’ section would be useful to include in the Dementia.ed site.

The People section didn’t resonate as the way to become part of the network

The EMHN site presented information for academic researchers to join the network in a ‘People’ section, which also contained information about the management of the network as well as researcher support resources. In the tests, participants struggled to find this content when tasked with finding out how to join the network, suggesting that a more explicit ‘How to join’ section would be more helpful to support this key task.

The Research section was too broad to usefully support specific tasks

Test participants gravitated towards the ‘Research’ section of the EHMN site for various tasks: to find research opportunities, to find help with research project development, to find content to support funding applications, to find out how to be a research participant and to find out how to financially support research activities.

On arrival in this section, when they realised it only contained content detailing different research activities, they went elsewhere. This suggested the need to separate out content about research activities from content supporting specific research-related tasks and to label it accordingly. In other words, instead of having a large, general ‘Research’ section, opt for smaller, more specific sections such as: ‘Research areas’, ‘Participate in research’ and ‘Donate’.

The new site has a flat structure, with content arranged by topic and tasks

Keeping site of the content strategy work, and using the results of testing the proxy site to make key decisions about structure, the new Dementia.ed site was built and launched.

The site contains six main sections, adopting a mix of topics and tasks to signpost the different sorts of content. The ‘About’ section contains background information about the dementia research network, with a dedicated page bringing together links to the different research centres and groups in a hub-and-spoke approach. A ‘What’s On’ section combines pages to Events and News content. The other four sections are labelled in task-focused ways, to ensure relevant audiences can quickly get to the content they need to complete their tasks: Join the network, Get involved, Contact us and Donate.

To ensure audiences reach content in the most direct way possible, the content in each section is either available as a top-level page, or a sub-page, avoiding long pages and deep hierarchies which may confuse those visiting the site.

Access the Dementia.ed website

If you need help architecting your website, get in touch

From start to finish, the process to design and launch the Dementia.ed website took a few months, including a few meetings between the UX Service and the ASDRC team, some short usability tests and an overall site review.

The ASDRC team provided the vision of what they wanted to achieve, and subject matter knowledge of their audience base and their associated tasks. With this information, the UX team could apply expertise to translate goals into a user-centred website, which is manageable for the ASDRC team to maintain.

We’re happy to offer help, advice and support to other University teams. If we can help, please contact us through the UX Service website.

Contact the UX Service

AI and Psychological Safety

20 October 2026 at 19:07

AI and Psychological Safety

When we opened this research pulse in March, we had some expectations about where we thought it would land. For individuals, especially neurodivergent folks, we expected AI to sometimes make speaking up a little easier; we’ve had many conversations in workshops with folks who have said they use AI tools as a way to rehearse a difficult conversation, or to find the words for something they want to say and aren’t sure how to put. For organisations though, we expected AI might pull us in the opposite direction, with the risk of jobs being replaced by AI and raising expectations about pace and quality of work leaving people feeling more precarious and that they have less room to get things wrong.

We asked three questions: whether you use AI tools at work, how that has affected how psychologically safe you feel with colleagues, and what’s behind your answer. 110 people replied. Some of what people told us matched our hypotheses closely, some of it somewhat complicated them, and one theme turned up that we hadn’t thought to look for at all.

The headline figures

Of the 90 people who use AI at work and answered our main question, the largest group said AI had made no real difference to how safe they feel with colleagues. The rest split in both directions, with about a third feeling safer and about a fifth feeling less safe.

For us, that spread is more interesting than the average. It points to several different experiences sitting side by side, and the comments people left to elaborate on their responses give an indication of what those experiences are.

AI is a place to rehearse

This was the clearest pattern in the comments, and it held up across people who otherwise appeared to have little in common. Those who said AI had made them feel safer mostly described using it to get ready for interacting with a colleague. One person has built meeting simulations and profiles of colleagues they find difficult, and now goes into tense meetings feeling much more prepared. Another asks it for “lines to take” because, in their words, “sometimes in the heat of a conversation I can’t immediately frame what I want to say well.” Someone else gets it to think like their manager and point out what they’re missing. One respondent described the whole cycle: practising emails, being coached through a situation with a colleague before speaking to them and stress-testing ideas before sharing them.

Only one person connected this to neurodivergence directly, explaining that they have ADHD and use AI to practise what they want to say.

All of these examples speak to change that happens in the person rather than in the team. Rehearsal helps us feel more prepared to walk into the room, and perhaps better able to predict what will happen next, even though the room itself, and what happens there when we say the thing, hasn’t changed.

One respondent raised a concern though around what might happen if rehearsal turns into replacement. A colleague had told them they talk things through with an AI chatbot, and this led them to wonder whether people who feel unsafe at work are now working through it with AI instead of raising it with a person, and whether that may leave them feeling more isolated. Rehearsal that leads into the real conversation looks like a potential benefit of using AI, but replacing interaction with AI conversation instead may leave the team less connected, and potentially feeling less safe than before. Interestingly, no one in our research described actually doing this, but the concern was there that others might. 

AI leaves less room to get it wrong

Our second prediction, that AI might make people feel less secure in their roles held up too, though the comments were actually a little more nuanced than we’d anticipated. Very few people who felt less safe said they were frightened of AI itself. What came through instead was a sense that their own value had become harder to see. One person summed it up in a phrase they’d heard from colleagues: “You can use AI for that.” Someone working with developers described the boundary between their roles blurring, so that it was suddenly obvious how little they knew about code, and the power, along with some impatience, now sat with the developers. Others wrote about AI adding strain to existing overload, feeling that it was “yet another thing to learn and be good at, just to prove I can do my job”. In a similar vein, others described feeling pushed into using it, and feeling that it was leading to workplaces where there was “more pressure and less time to think”.

Admitting you don’t know something is one of the everyday risks that a psychologically safe team makes affordable. When AI seems to make those gaps in knowledge less forgivable, and is perceived to be continually raising the bar for performance at work, understandably people are going to find it harder to admit when they don’t know.

One comment pointed to where this might lead: “There’s worry about competence gap, there’s more isolation, more ‘team of one’ than before.” If people respond to feeling exposed by withdrawing, the team loses the conversations that would help everyone work out how best we work with this rapidly evolving technology.

Keeping it to yourself: stigma around AI use

Separate from worries about jobs, a handful of people described AI use as something they keep from colleagues, perhaps because in certain areas it is considered lazy, or even a form of cheating. Someone in academia put it bluntly: “everyone is using AI, but nobody dares admit it. The choice is either to use it and pretend we’re not, or not use it, and be left behind.” Another, also from higher education, said AI can feel like cheating, and wondered whether acknowledging it diminishes their capabilities in the eyes of their team. Given that so much of the discussion in higher education has been around detecting and potentially punishing students for inappropriate AI use, it makes sense that staff would find it hard to say openly that they use it themselves.

A trainer who has seen similar fears play out with e-learning described themselves as a “quiet AI enthusiast”, because their colleagues are scared enough that discussing how to use AI at work doesn’t feel safe. A team leader told us their own position makes it less risky for them to be honest about using AI, while recognising that people in their team seem nervous about saying what they use it for.

This isn’t the case across all teams and organisations, and indeed some respondents described a very different experience. One respondent who felt much safer wrote: “We all use AI in some form and discuss our use openly. We have frameworks to govern how we use it.” Another team treats anything from AI as not fully credible by default, which they said gives them an easy way to start conversations and question assumptions together. 

It seems openness and transparency around use, and guardrails of using AI help to make it a safe conversation. 

The biggest group: no change, for now

The largest single answer was to how AI was affecting people’s psychological safety was “no change”, and the reasons people gave for it fall into two camps. One was the people who are using AI but not in a way which has (yet) impacted on their interactions with colleagues, the things that actually shape psychological safety. One person, for instance, uses AI only as a starter for ideas and then abandons it; others said they’re “still at the experimenting stage” or that it’s early days where they work. For them, AI hasn’t yet reached the part of work that happens between people, so it’s had little chance to change how safe that feels. One respondent also captured the job security angle of this, saying fear of being fired isn’t a threat for them, “yet”.

The second camp said their team was already a safe place to speak up, and AI hadn’t shifted that. One described a very psychologically safe culture where the conversation about AI had been transparent from the start; another said their workplace had given people time in workshops to explore it together. That fits the pattern in the previous section. Where AI arrives into a team that already talks openly, and people are given time and space to explore AI, people can then talk openly about AI too.

Psychological Safety by proxy

Writing in HBR, Jayshree Seth and Amy Edmondson describe what they call safety by proxy: people using AI to surface a concern when they don’t feel safe enough to raise it directly. They argue that when that happens, it tells leaders something about the culture.

Nobody in our survey described passing a concern onto the team through AI in place of saying it themselves, but the person who described their team openly acknowledging the fallibility of AI as an easy way into questioning assumptions hits on an important point. If the idea on the table belongs to the tool and not to a colleague, it can be easier to critique it without worrying about the interpersonal cost. It is easy to see how that may extend to presenting your own ideas or concerns through AI as a way of slightly distancing yourself from them and lowering the perceived interpersonal cost of raising them. 

A group that needs a proxy at the interface before it can disagree is a group where disagreeing directly still feels risky. Safety by proxy might become a rehearsal for the ‘real thing’ of disagreeing person to person. It might just as easily become a more comfortable way to avoid it completely.

What this means for teams and managers

One interpretation of this is that AI amplifies whatever a team already does with uncertainty. Where people can say what they’re trying, what they don’t understand and what worries them, AI becomes one more thing to learn about together. Where they can’t, it becomes one more thing to manage alone.

For managers, that points to a few practical suggestions:

  • Go first. Say how you use AI, including where it has gone wrong for you. The team leader in our survey noticed that seniority made disclosure less risky for them, which makes them the person best placed to take the first step.
  • Make “I don’t know how to do this yet” an ordinary thing to say. The people who felt least safe were the ones who felt exposed by having gaps in their knowledge.
  • Agree how the team uses AI, explicitly. Several of the people who felt safest had shared ground rules, or a shared habit of treating AI output as a starting point for discussion. Shared norms make the space more predictable and therefore (usually) safer.
  • Notice if anyone has gone quiet or appears to be pulling away from the team. If someone has become a “team of one”, ask what’s changed for them.
  • Welcome the rehearsal, whilst encouraging people to make sure the real conversation still happens afterwards.

The most hopeful comment in the whole survey was also one of the shortest. “We all use AI in some form and discuss our use openly.” What matters when it comes to psychological safety perhaps isn’t the use of AI as much as the habit of talking about it; making AI itself a safe topic of conversation. 

About the data

This research pulse ran on an open survey link from 25 March to 6 October 2026, with a sticker-pack prize draw as a thank you. We received 110 responses (97 complete and 13 partial). 96 people said they use AI tools at work, and 90 of them answered the question about psychological safety. Around 60 left a comment.

It’s a small, self-selected sample, and people who already care about psychological safety are more likely to have taken part, so we should read the findings as a snapshot of experiences rather than a measure of how universally common they are. The themes above reflect our reading of the comments. Quotes have been lightly tidied for typos, and we’ve left out anything that might identify the person who wrote them.

Thank you to everyone who took the time to answer, and especially to those who told us what was behind their answer.

Further reading:

What leaders need to know about AI and psychological safety 

Academic integrity has become a pedagogy of suspicion

The post AI and Psychological Safety appeared first on Psych Safety.

New Research Strengthens the Case for Emotional Dysregulation in ADHD Criteria

23 October 2026 at 08:33

When the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) was updated in 2022, officials believed that research was lacking to expand ADHD’s definition to include the common and extremely impairing symptom of emotional dysregulation. Consequently, the overwhelming and uncontrollable emotions reported by many patients remain largely unrecognized as ADHD manifestations.

Now research appears to be catching up to patient reports.

A new landmark study has revealed three ADHD subtypes that reflect neurobiological differences: predominantly inattentive; predominantly hyperactive/impulsive; and the new severe-combined, which is marked by emotional dysregulation.1

Using neuroimaging and computational modeling to map the pathways of ADHD, researchers found that the severe-combined type had 45 areas of brain abnormality tied to emotion and control compared with 26 each for the two other types. The study, which analyzed 1,154 brain scans of children and adolescents with ADHD, was published recently in JAMA Psychiatry.

New Presentation, New Treatment?

The findings are “an example of recent insights emerging from neuroimaging that may impact clinical care, which has been an elusive goal,” says F. Xavier Castellanos, M.D., professor emeritus of child and adolescent psychiatry at New York University’s Grossman School of Medicine. He was part of the working group that contributed to the DSM-5.

[Get This Free Download: Emotional Regulation & Anger Management Scripts]

“Still, it’s too early to assume that their intriguing results are real in the sense of replicating repeatedly in independent datasets, particularly by investigators who are not allied or collaborating with the original research team,” says Castellanos. He, like the study authors, calls for prospective studies to validate their biotypes and determine whether they may influence treatment.

Findings that reveal a new severe-combined subtype may come as no surprise to the thousands of parents of children with ADHD, and adults with the condition, who have named emotional dysregulation as the most impairing feature of ADHD in ADDitude surveys.

But, as David Anderson, Ph.D., senior psychologist at the ADHD and Behavior Disorders Center at the Child Mind Institute, points out, parents’ anecdotal feedback precedes scientific validation.

“Finding evidence of a subtype in the brain leaves open questions about the balance of nature versus nurture. Is there a biological basis for subtypes and is it reliable across the span of development?” Anderson asks. “Emotion dysregulation can be biological for kids who are more prone to emotional behavior from an early age, while some are frustrated with the world due to negative feedback they’ve gotten since kindergarten, so it’s environmental. There are multiple pathways to come to this.”

[Read: The Key to ADHD Emotional Regulation? Cultivating Gratitude, Pride & Compassion]

If the study’s findings are replicated, Castellanos says, it would become a new presentation in a future version of the DSM. “I served on the DSM-5 committee, and we were explicitly reminded that the DSM follows the field; it does not lead it. It’s only when the scientific evidence is strongly supportive that DSM changes are allowed. Otherwise, it’s too disruptive.”

Stephen V. Faraone, Ph.D., distinguished professor at SUNY Upstate Medical University, said he believes that emotional dysregulation was not included in the DSM-5 because it might have made differential diagnosis with anxiety and mood disorders more difficult, especially in primary care. He also said he was skeptical that ADHD can be divided into biological subtypes, adding that underlying ADHD brain mechanisms exist along a spectrum and do not fall neatly into separate categories.

The study’s researchers said the findings may eventually create a path toward developing personalized therapeutic strategies.

Emotional Dysregulation: Next Steps

Carole Fleck is Editor-in-Chief at ADDitude magazine.


ADDITUDE IS HUMAN
Artificial intelligence does not create or edit any written content published by ADDitude. Our editorial team is 100% human, and our mission is simple: listen to and serve our readers with hand-crafted, expert-informed resources. To support ADDitude, please consider subscribing. Your readership and support help make our commitment possible. Thank you.


Sources

1Pan, N., Long, Y., Qin, K., et al. (2026). Mapping ADHD heterogeneity and biotypes by topological deviations in morphometric similarity networks. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2026.0001

Study: Narcolepsy Medication Found to Improve Adult ADHD Symptoms

21 October 2026 at 17:27

October 21, 2026

An investigational narcolepsy medication called ALKS 7290, an orexin 2 receptor (OX2R) agonist, offers a new therapeutic approach for ADHD, according to results from a recent Phase 1B proof-of-concept study. ALKS 7290 is the first OX2R agonist to demonstrate clinically meaningful improvements in ADHD symptoms in adults with the condition, according to the drug’s manufacturer Alkermes plc.1

“OX2R agonists will represent an entirely new class of ADHD treatment, breaking the traditional barrier between stimulants and non-stimulant treatment,” says Greg Mattingly, M.D., a consultant on the Phase 1 and upcoming Phase 2 trials.

Stimulants remain a first-line treatment for ADHD in adults. However, not all patients tolerate the side effects of or see benefits from stimulant medications. According to an ADDitude survey of more than 11,000 adults with ADHD, 78% of respondents taking amphetamines and 70% of those taking methylphenidate experienced some side effects, compared to 66% of adults taking non-stimulant medications.

How OX2R Agonists Work

The drug works by selectively binding to and activating orexin type 2 receptors, proteins in the brain that regulate alertness, arousal, and appetite. This targeted approach could minimize potential side effects and drug misuse, according to Mattingly.

“Unlike traditional stimulants, orexin 2 receptor agonists have no direct effect on dopamine reuptake or release,” says Mattingly, Associate Clinical Professor in the Department of Psychiatry at the Washington University School of Medicine. “Orexin 2 receptor agonists modulate pathways in the brain that are associated with vigilance, reward, and alertness while decreasing impulsivity. By minimizing direct effects on dopamine reuptake or release, they are considered to have a lower abuse potential.”

The two-week double-blind, parallel-group trial included 50 adults with ADHD and 88 adults without. Participants with ADHD were randomly assigned to receive ALKS 7290 at a total daily dose of 20 mg or 50 mg in split doses or placebo.

As early as day six, patients taking ALKS 7290 demonstrated clinically meaningful improvements in ADHD symptoms, as measured by the Adult ADHD Investigator Symptom Rating Scale (AISRS), and in overall ADHD severity, as measured on the Clinical Global Impression-Severity Scale (CGI-S).

By day 14, treatment with ALKS 7290 reduced median baseline AISRS total scores by 14 points for the 20 mg dose and 19 points for the 50 mg dose. Median CGI-S scores declined by one point with the 20-mg dose and two points with the 50-mg dose.

ALKS 7290 was generally well tolerated at both doses, with mild side effects including insomnia, dizziness, change in sustained attention, and constipation.

Using an Orexin 2 Receptor Agonist to Treat Coexisting Conditions

The ORX2 agonist also shows promise in treating narcolepsy type 1 (NT1), a common co-occurring condition with ADHD. (Approximately 25% of people with narcolepsy have ADHD.).2 In August, the U.S. Food and Drug Administration approved Orzeyful (oveporexton), a first-in-class OX2R agonist tablet indicated to treat narcolepsy type l (NT1) in adults.3 Takeda Pharmaceuticals, Orzeyful’s manufacturer, expects the drug to be available in November 2026, pending DEA scheduling.

NT1 is a chronic sleep disorder, characterized by excessive daytime sleepiness (EDS), sudden sleep attacks, cataplexy, and sleep disruptions, resulting from a deficiency in orexin-producing neurons.4

ADHD and narcolepsy share several overlapping symptoms related to arousal and wakefulness. Before becoming standard ADHD treatment, stimulants like amphetamine and methylphenidate were used to treat excessive daytime sleepiness found in narcolepsy patients.5

“Our longest surveillance of the safety of amphetamine comes from following people with narcolepsy for their entire lives,” says ADHD expert William Dodson, M.D., LF-APA. Today, Ritalin (methylphenidate) and Adderall (amphetamine) are both central nervous system stimulant medications approved for the treatment of ADHD and narcolepsy in adults and children.

While it is too soon to know if the OX2R agonist used to treat narcolepsy will likewise evolve into a standard ADHD treatment, the parallels to stimulant medications are clear.

“What’s exciting for clinicians was the fact that ALKS 7290 had dose-related improvement in ADHD symptoms with dramatic improvement seen early and sustained throughout the two-week study,” says Mattingly, founding partner of St. Charles Psychiatric Associates. “While preliminary, the level of improvement obtained with this molecule after two weeks was similar to what is typically seen after four to six weeks in a trial of methylphenidate or amphetamine molecules for ADHD treatment.”

Results from a Phase 2 clinical trial evaluating the efficacy and safety of ALKS 7290 in adults with ADHD are expected in 2027.

Sources

1 Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD). Press Release. September 21, 2026. Accessed October 15, 2026. https://investor.alkermes.com/news-releases/news-release-details/alkermes-announces-positive-phase-1b-results-demonstrating

2 Ren, Jiafeng, Zhao, Xianchao, Su, Changjun, et. al. (2024). ADHD in narcolepsy: A closer look at prevalence and ties. Neuroscience & Biobehavioral Reviews. https://doi.org/10.1016/j.neubiorev.2023.105471

3 FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms. Press Release. August 5, 2026. Accessed October 15, 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-full-range-narcolepsy-type-1-symptoms

4 Krahn, L.E., Zee, P.C., Thorpy, M.J. (2022) Current understanding of narcolepsy 1 and its comorbidities: what clinicians need to know now. Adv Ther. https://doi.org/10.1007/s12325-021-01992-4

5 Konofal, Eric. (2024). From past to future: 50 years of pharmacological interventions to treat narcolepsy. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2024.173804

IBS, Stomach Pain, and Other GI Symptoms Strongly Tied to ADHD: New Review

9 October 2026 at 16:15

October 9, 2026

People with ADHD are 48% more likely than their neurotypical peers to experience gastrointestinal (GI) issues, including irritable bowel syndrome (IBS), encopresis, dyspepsia, and constipation, according to a large scale review published in the Journal of Attention Disorders.1

Data from 1.9 million individuals with ADHD aged 2 to 65 was included in the review of 23 studies. While past studies have explored the association between ADHD and intestinal diseases, such as celiac disease and peptic ulcers,2 this is the first review to examine the association between ADHD and GI symptoms, broadening the scope of the investigation to include those without a formal diagnosis of a GI disorder. The findings, wrote the study’s authors, suggest that past studies “may have underestimated the burden of functional bowel dysfunction in people with ADHD and highlights the importance of analyzing symptom-level data.”

The study found that people with ADHD face increased odds of experiencing GI symptoms investigated, including the following:

  • Encopresis: 300% higher odds
  • Diarrhea: 100% higher odds
  • Constipation: 97% higher odds
  • Abdominal pain: 88% higher odds
  • IBS: 58% higher odds
  • Dyspepsia: 52% higher odds

A recent ADDitude survey exploring readers’ experiences with inflammation found similarly high rates of gastrointestinal disorders.

  • 32% of ADDitude readers said they have IBS, compared to 5% to 17% in the general population
  • 6% reported irritable bowel disease (IBD), compared to less than 1% in the general population
  • 6% reported celiac disease, compared to 1.5% in the general population

Possible Mechanisms

The study’s authors offered several possible explanations for the demonstrated association between ADHD and GI symptoms.

ADHD Traits and Behaviors

Traits characteristic of ADHD, including impulsivity, emotional dysregulation, sensory sensitivities, and poor interoception, may disrupt digestion and lead to behaviors that contribute to GI symptoms.

  • Impulsivity can lead to irregular mealtimes, skipped meals, and binge eating.
  • Emotional dysregulation and heightened stress responsiveness can contribute to abdominal pain.
  • Sensory sensitivities can lead to restricted food choices, prompting GI symptoms such as constipation.
  • Poor interoception can delay meal timing, as well as disrupt use of the bathroom, contributing to constipation or encopresis.

ADDitude readers observed many of these connections between ADHD symptoms and digestive challenges.

“My IBS gets bad when my ADHD keeps me from doing basic things like taking my probiotics or drinking my fiber supplement every day and remembering to renew the medications,” wrote Alex from New Jersey.

“I’ve had SIBO before, and I’m trying very hard not to get it again,” wrote Jennifer from Texas. “Between fructose malabsorption and a delayed stomach, I can’t eat most foods, so every meal involves prep — and prep is exactly the thing executive dysfunction makes impossible!”

“The irritable bowel issue is made worse by stress and anxiety, which is a part of my ADHD,” explained Sarah, an ADDitude reader in the United Kingdom. “When my stomach feels bad, I can’t think as clearly, and my ADHD is worse. They both affect each other.” 

Gut Microbiome

Building on past studies that have found differences in the microbiota of those with and without ADHD,3 the study’s authors posit that gut microbiome may be a key player. “There is a clear link between gut health and the brain, yet the exact mechanism of the gut-brain axis is not yet clear,” they write. “One theory is the vagus nerve acting as a bidirectional pathway of communication between the brain and the gut.”

This communication was explored in a 2025 ADDitude webinar titled “The Surprising Association Between ADHD & Inflammation,” with James Kustow, BMedSci, BMBS, MRCPsych. “Problems with the digestive system frequently occur in people with ADHD, impeding gut motility and nutrition, and causing chronic pain and discomfort,” Kustow said. “The autonomic nervous system is responsible for the peristaltic movement through the gut, so dysautonomia causes sluggish gut. Mast cells in the gut that get activated cause swelling, which limits flow. The combination of poor peristaltic movement and inflammation causes the contents of the gut to stagnate, leading to gastrointestinal problems.”

“What happens in the gut does not stay in the gut,” explained Miguel Toribio-Mateas, DProf, MSc, BSc (Hons), CBiol, in the 2026 ADDitude webinar, “How Gut Health Impacts ADHD Symptoms: New Insights on Food, Microbes, and Inflammation.” “The gut will contribute to conditions such as ADHD as well as other coexisting conditions… in the neurosphere — anxiety, depression, and so on.”

Side Effects of ADHD Medications

Stimulant medications used to treat ADHD often suppress appetite, which can impact digestive processes, and may cause nausea and abdominal pain.4,5 “ADHD medications have given my daughter a lot of upset stomach, leaky gut, inflammation with her skin, and other problems processing the medication,” said Sandra, an ADDitude reader from Canada.

Since the studies included in the review did not segment the data by medication status, the authors could not assess the influence of medication side effects. They explained, however, that several of the GI symptoms most prevalent among ADHD patients — constipation and encopresis — are not common side effects of stimulants, suggesting that non-pharmacological explanations are at play.

Implications for Patient Care

The study’s authors hope their findings will raise clinicians’ awareness of a complex and under-recognized association. “Healthcare workers should be aware of this increased risk of GI symptom presence and should actively ask about GI symptoms during consultations… ensuring that these issues are not overlooked,” they wrote.

Understanding the relationship between ADHD and somatic conditions, including GI disturbances, has been highly instructive for Rebecca, an ADDitude reader from Chicago. “It’s been a tiny relief to learn that some of the things that trip me up, like GI issues that make me late to work might not be just a failure of my willpower or my ADHD meds,” she said. “Pulling apart more strands of what’s happening to me makes it a little clearer which challenges might be treated differently than just throwing the ADHD meds at them. This gives me hope that I might be able to access a whole other set of tools and treatments.”

Sources

1Blake, S., Cannon, H., & Shantikumar, S. (2026). The Association Between Attention-Deficit Hyperactivity Disorder and Gastrointestinal Symptoms: A Systematic Review and Meta-Analysis. Journal of Attention Disorders, 0(0). https://doi.org/10.1177/10870547261469626

2Ng, R.W., Chen, Z., Yang, L. et al. Association between attention-deficit/hyperactivity disorders and intestinal disorders: A systematic review and Meta-analysis. Sci Rep 15, 19278 (2025). https://doi.org/10.1038/s41598-025-04303-x

3Jakobi B., Vlaming P., Mulder D., Ribases M., Richarte V., Ramos-Quiroga J. A., Tendolkar I., van Eijndhoven P., Vrijsen J. N., Buitelaar J., Franke B., Hoogman M., Bloemendaal M., Arias-Vasquez A. (2024). The gut-microbiome in adult Attention-deficit/hyperactivity disorder – A meta-analysis. European Neuropsychopharmacology, 88, 21–29. https://doi.org/10.1016/j.euroneuro.2024.07.004

4Holmskov M., Storebø O. J., Moreira-Maia C. R., Ramstad E., Magnusson F. L., Krogh H. B., Groth C., Gillies D., Zwi M., Skoog M., Gluud C., Simonsen E. (2017). Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: A systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials. PLOS ONE, 12(6), Article e0178187e0178187. https://doi.org/10.1371/journal.pone.0178187

5Kedem S., Yust-Katz S., Carter D., Levi Z., Kedem R., Dickstein A., Daher S., Katz L. H. (2020). Attention deficit hyperactivity disorder and gastrointestinal morbidity in a large cohort of young adults. World Journal of Gastroenterology, 26(42), 6626–6637. https://doi.org/10.3748/wjg.v26.i42.6626

Nearly Half of Children with ADHD Have Sleep Apnea: New Study

18 September 2026 at 21:56

September 18, 2026

Rates of obstructive sleep apnea (OSA) are significantly higher among kids with ADHD, according to a systematic review published in the Journal of Attention Disorders.1 that found 44% of children with ADHD also had OSA.

Three research databases were searched, resulting in an analysis of 11 longitudinal studies involving 903 children formally diagnosed with OSA or ADHD. Using a random-effects meta-analysis, researchers found that the pooled prevalence of OSA in children with ADHD was 44%. They also found that adenoidectomy, a surgical procedure to remove the adenoid glands, consistently led to significant improvements in OSA and ADHD symptoms.

OSA is a sleep-related breathing disorder in which the muscles that keep the upper airway open relax too much during sleep, causing the airway to narrow or collapse. This, in turn, leads to a drop in oxygen and night wakings, which fragment sleep.

The disturbed sleep caused by OSA can result in symptoms that heavily overlap with those of ADHD, including decreased concentration, issues with memory and other executive functioning such as problem solving and planning. Previous research has demonstrated that co-occurring OSA can exacerbate these symptoms in patients with ADHD.

“Not only does ADHD cause sleep problems, but sleep problems aggravate ADHD symptoms,” explained J.J. Sandra Kooij, M.D., Ph.D., in the ADDitude article “The Disorder That Never Sleeps.”

Wes Crenshaw, Ph.D., echoed this observation in the ADDitude article, “What Comes First: ADHD or Sleep Problems?” “Few things impact mental health more than sleep,” he wrote. “Poor or insufficient sleep makes almost every psychological problem worse. With ADHD, that link is obvious and complicated, because there are several ways sleep and ADHD affect each other.”

How Poor Sleep Amplifies ADHD Symptoms

According to ADDitude readers, sleep issues are ubiquitous — and among the most challenging parts of living with ADHD. A recent ADDitude sleep survey of 2,156 readers revealed the scope and depths of sleep problems, with up to half of kids and adults with ADHD reporting symptoms similar to those associated with OSA.

Diagnosed OSA rates were significantly lower:

  • 25% of adults with ADHD reported an OSA diagnosis
  • 9% of children and teens with ADHD also had an OSA diagnosis

Proper diagnosis of OSA and other sleep disorders is critical for both physical and mental wellbeing, as treatment via continuous positive airway pressure (CPAP) machine or adenoidectomy has been shown to improve symptoms of ADHD as well.

“Physicians should be cognizant of this association,” wrote the study’s authors. ”And consider concurrent evaluation for OSA in children with ADHD symptoms, which can effectively guide treatment strategies.”

Sources

1Leow, B. H. W., Tan, C. J.-W., Yeo, B. S. Y., Ng, N. N. E., Low, S. C. Y., Ng, A. C. W., Teoh, O. H., Toh, S. T., & Tay, E. G. H. (2026). Association between Attention Deficit Hyperactivity Disorder and Obstructive Sleep Apnea in Children: A Systematic Review and Meta-Analysis. Journal of Attention Disorders, 30(6), 822-832. https://doi.org/10.1177/10870547261426094

Do ADHD Meds Stunt Growth? A New Stimulant Study Says No

18 September 2026 at 20:30

September 18, 2026

Long-term stimulant use for ADHD negligibly affects adult height, according to a new cohort study published in Pediatric Research that tracked 64,775 children for up to 28 years.1

Parents making ADHD treatment decisions commonly worry that prescription stimulants will stunt their child’s growth. In a 2024 ADDitude survey of 11,000 readers, less than half (42%) of parents chose to medicate their children in the months following an ADHD diagnosis. Those respondents cited side effects like appetite suppression or sleep disruption — both possible impediments to growth — as influences on their decision.

Murky or conflicting findings from previous studies have done little to ease caregivers’ worries.

“Many prior studies either did not follow participants to adult height, so reported effects may reflect delayed maturation rather than true adult height deficits, or they did not account for genetic height potential, which may confound results,” the study’s authors wrote.2, 3

The Pediatric Research study followed a different methodology. It measured the impact of ADHD and stimulant treatment on an individual’s adult height relative to their expected genetic height potential, based on their parents’ heights. Taking an individual-level normalization approach accounted for familial genetic height potential, reducing uncertainty from delayed maturation and group-level bias.

The researchers used health records from a nationwide provider to assemble a retrospective cohort of 17,517 children with treated and untreated ADHD, plus 47,258 in a control group, all born between 1995 and 2003. (Of those with ADHD, 11,846 received stimulant treatment, and 5,671 did not.) They followed the children through 2023 to ensure they reached adult height, defined as at least age 17 for girls and age 19 for boys.

When they compared adult heights across the three groups using an ANOVA (analysis of variance), they found statistically detectable but clinically negligible effect sizes in adult height for girls with ADHD taking stimulant medication and non-significant differences in adult height for boys with ADHD who were treated with stimulants.

“The large sample size increases the likelihood of detecting statistically significant but trivial differences; therefore, effect size analysis is essential for interpreting practical relevance,” the study’s authors wrote.

The effect sizes were consistently very small, and the physical difference measured between the groups was less than a centimeter, which is below the typical range considered clinically meaningful and within the range of routine measurement error.

“Given the very small effect sizes and sub-centimeter absolute differences, clinicians and families can be reassured that decisions regarding stimulant therapy need not be driven primarily by concerns about potential reductions in adult height,” the study’s authors wrote.

Sources

1Gabbay, M., Gabbay, U. and Carmi, D. (2026). The impact of ADHD and neurostimulant treatment on normalized height deviance after accounting for genetic height potential. Pediatric Research. https://doi.org/10.1038/s41390-026-04929-1
2Spencer, T.J. et al. (1996). Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays. J. Am. Acad. Child Adolesc. Psychiatry.  https://doi.org/10.1097/00004583-199611000-00014
3Biederman, J. et al. (2003). Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment. Pediatrics. https://doi.org/10.1542/peds.111.5.1010

Study: Methylphenidate Use Benefits Daily Functioning, Performance at Work

17 September 2026 at 01:41

September 17, 2026

Methylphenidate (brand name: Ritalin) use is associated with real-time improvements in both ADHD symptoms and daily functioning at work, which continue to strengthen over time in adults with ADHD, according to a new exploratory study published in the Journal of Attention Disorders.1

Of participants with ADHD who received methylphenidate:

  • 39.6% showed improvement in both symptoms and functioning
  • 33.8 % showed improvement in symptoms but not functioning
  • 4.3% showed improvement in functioning but not symptoms

Within the placebo group, symptoms and functioning improved in 26% of participants, and 43.8% demonstrated no improvement on either measure.

The findings suggest that evaluating symptom improvement alone isn’t enough to determine whether a patient is receiving optimal treatment. Clinicians should also consider how ADHD medication impacts a patient’s daily functioning, such as their ability to arrive at work on time, perform job functions reliably, and meet productivity goals at work.

“The evaluation of symptoms alone may be a relatively weak method of determining if a patient is actually being optimally treated,” the study’s authors wrote. “Symptom change may be more immediate and more sensitive to medication treatment, but robust symptom change is associated with the functional response that is the more meaningful target of treatment.”

The study included a four-week double-blind clinical trial followed by a six-month open-label (OL) follow-up phase. The researchers measured symptoms and functional changes before and after the study period using the ADHD Rating Scale-5 (ADHD-5-RS), the Clinical Global Impressions Improvement scale (CGI-I), and the Weiss Functional Impairment Rating Scale—Self Report (WFIRS-S). (The WFIRS-S evaluates how the patient feels their emotional and behavioral symptoms impact their level of functioning in the following domains: Family, Work, School, Life Skills, Self-Concept, Social, and Risky Activities.)

For the clinical trial, 351 adults with ADHD aged 18 and older took extended-release methylphenidate ranging from 25 mg to 100 mg or placebo once daily. At the end of the four weeks, 40% of those taking methylphenidate showed significant functional improvement, and 47.5% were rated as “improved” or “very much improved” on the CGI-I. Symptoms continued to improve, with 14% of improvement occurring in the last four months of the six-month OL phase.

Clinicians titrated methylphenidate doses to the point of optimal improvement during the OL phase. By the sixth month, 66.7% of the 124 participants achieved both symptomatic and functional improvement across all WFIRS-S domains.

Stimulant Treatment Associated with Improvements in Job Performance

Work was the only WFIRS-S domain in which participants taking methylphenidate showed significant improvements compared with the placebo group during the double-blind clinical trial and the OL follow-up. (The Work domain assessed job performance, punctuality, job retention, productivity, and work potential.)

The association between methylphenidate treatment and improved work-related functioning may offer hope for adults with ADHD, who face a substantially higher risk of career instability and unemployment.2, 3

In 2024, a longitudinal study of nearly 7,000 participants in the Journal of Attention Disorders found that individuals with comorbid ADHD and oppositional defiant disorder symptoms face higher unemployment rates, lower overall income, and more frequent sick days in adulthood compared to their neurotypical peers.4

Many ADDitude readers have experienced firsthand how ADHD symptoms can impact employment status and job performance.

“I have lost plenty of jobs due to my ADHD symptoms,” wrote Tim, from North Carolina. “However, I was unmedicated for many years and didn’t realize that I was struggling because of my ADHD.”

“I left my most recent job because I couldn’t handle all the details in the paperwork,” said Dawn from Virginia. “I just kept missing things. It wasn’t a good fit.”

“I suffered from severe burnout from a job that wasn’t suited for my ADHD brain,” another reader said. “It resulted in severe exhaustion and depression and became so serious that I lost the ability to continue employment. I’ve been surviving on disability benefits since.”

While more research is needed to determine which parts of an adult’s daily life respond best to stimulants, and how doctors can fine-tune ADHD medication doses for each patient, the study’s authors are encouraged by their findings.

“The take-home message for clinicians is that stimulant treatment of adults with ADHD can be anticipated to lead to functional improvement in most patients and optimized functional impairment over time in more than half of patients,” they wrote.

Sources

1Weiss, M.D., Newcorn, J.H., Donnelly, G.A.E. et al. (2026). An exploratory study of functional outcome in stimulant treatment of ADHD in adults. Journal of Attention Disorders. https://doi.org/10.1177/10870547261440452

2 Jangmo, A., Kuja-Halkola, R., Pérez-Vigil, A., et al. (2021). Attention-deficit/hyperactivity disorder and occupational outcomes: the role of educational attainment, comorbid developmental disorders, and intellectual disability. PLoS One. https://doi.org/10.1371/journal.pone.0247724

3Jervan, B., Torgersen, T., Nordahl, H.M., & Rasmussen, K. (2012). Functional impairment and occupational outcome in adults with ADHD. J Atten Disord. https://doi.org/10.1177/1087054711413074

4 Seppä, S., Huikari, S., Korhonen, M., Nordström, T., Hurtig, T., & Halt, A.-H. (2024). Associations of symptoms of ADHD and oppositional defiant disorder (ODD) in adolescence with occupational outcomes and incomes in adulthood. Journal of Attention Disorders. https://doi.org/10.1177/10870547241259329

New Research: Sex Differences Impact ADHD Symptoms, Treatment Efficacy

16 September 2026 at 18:57

September 15, 2026

Sex differences exert a significant and complex impact on ADHD symptoms, treatment, and risk of co-occurring conditions, according to the findings of several recent studies.

Most recently, researchers from Denmark found that individuals with ADHD faced relatively greater risk of developing 13 physical conditions, and that risk ratio was significantly affected by the sex of the patient.1 Research on the impact of menstrual cycle hormones on ADHD symptoms further illuminated the notable influence of sex on ADHD symptomatology and impairment.2 Finally, a study on the efficacy of cognitive behavioral therapy (CBT) for adolescents with ADHD also revealed differences across the sex divide.

Sex Impacts Risk of Physical Conditions

People with ADHD demonstrate a higher risk for 13 physical conditions, including endocrine, metabolic, and eye conditions, according to a study that used medical records of more than 800,000 Danish individuals. The study, published in the Journal of Attention Disorders, found that individuals diagnosed with ADHD showed a higher risk for all conditions, apart from malignant neoplasms, beginning in adolescence.

Having an ADHD diagnosis did not raise this risk equally for men and women, however.

In the general population, females were at a higher risk of most physical conditions beginning in adolescence. Specifically, females were nine times more likely to have an endocrine, nutritional, or metabolic disorder beginning in young adulthood. However, when researchers measured rates in females with an ADHD diagnosis, the relative prevalence fell by half.

In another case, males in the general population had a 15% higher risk than females of developing eye and adnexa diseases in childhood. Among those with an ADHD diagnosis, though, this trend was reversed; females had double the risk of males.

Sex and Hormonal Fluctuations Impact Symptoms

One notable difference in ADHD presentations between males and females stems from fluctuating symptoms over the menstrual cycle. The impact of estrogen on ADHD has been a primary research focus for Michelle Martel, Ph.D., chair of the psychology department at the University of Kentucky, who wrote this in the ADDitude article “Hormonal Changes in Women with ADHD: 4 Gaping Holes in Research:” “Each menstrual cycle brings hormonal peaks and valleys that significantly influence ADHD symptoms. Our recent research confirms that anxiety, mood, and attention all worsen as estrogen falls during the luteal phase.”

Prompted by the promising findings of a small study in 2018,4 Martel conducted a larger-scale study on ADHD symptoms and menstrual hormones. She recently presented her findings at the U.S. Psychiatric and Mental Health Congress.

Martel’s team collected daily measurements of hormone levels and ADHD symptoms from 97 female college students with an ADHD diagnosis and found ADHD symptoms, including impulsivity and inattention, increased in the days preceding and beginning their period.

“These studies have dramatic assessment and treatment implications,” Martel stated in a press release. “We should be paying attention to these things when we’re doing assessments, and then also we may want to change our treatments or personalize our treatments based on where women and girls are across their lifespan.”

Sex Impacts Efficacy of Treatment

A third study exploring yet another facet of sex differences focused on the varying impact of CBT on adolescent males and females with ADHD. Data from 200 teens who participated in randomized control trials in Norway or the Netherlands was analyzed.

According to parent reports, CBT significantly improved ADHD symptoms generally, however this improvement varied depending on the patient’s sex as well as accompanying symptoms of depression.

  • CBT led to a significantly smaller reduction in ADHD symptoms for girls with higher levels of depression symptoms, compared to boys with these symptoms.
  • For girls, receiving individual CBT (versus group CBT), led to double the improvement in ADHD symptoms.

Each of these studies sheds light on the highly complex and variable nature of ADHD symptoms, treatment, and co-occurring conditions and the still poorly understood ways in which sex differences may affect these realms.

Sources

1Villumsen, M. D., Bilenberg, N., & Steinhausen, H.-C. (2026). Sex Differences in the Association Between Attention-Deficit Hyperactivity Disorder and Physical Diseases in Childhood and Adolescence Using Nationwide Birth Cohorts. Journal of Attention Disorders, 0(0). https://doi.org/10.1177/10870547261448260/

2Harper K. How menstrual periods can affect ADHD symptoms and treatment. Scientific American. May 2026. https://www.scientificamerican.com/article/adhd-symptoms-can-fluctuate-with-the-menstrual-cycle/

3Hanes, T. K., Andersen, A. C., Boyer, B. E., & Wagner, K. (2026). Gender Differences in Cognitive Behavioral Therapy Outcomes for Adolescents With ADHD: Examining the Impact of Internalizing Symptoms. Journal of Attention Disorders, 30(7), 945-954. https://doi.org/10.1177/10870547251415431

4Roberts B, Eisenlohr-Moul T, Martel MM. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018;88:105-114. doi:10.1016/j.psyneuen.2017.11.015.

What I learned in my summer internship researching digital content accessibility

11 September 2026 at 14:30

In this post, User Experience team intern Hannah Watson shares her work over the summer researching digital content accessibility with the EdWeb 2 publishing community.

Introduction

As part of my internship with the User Experience Service, I have been investigating digital accessibility at the content level across University web pages, particularly on EdWeb 2 sites. Digital accessibility at the content level is about applying principles of accessibility to how web content is written and formatted. This includes, but is not limited to, content features such as heading levels, links, and alt text. It does not include anything that is not involved with content design or that is controlled at a higher level by the Content Management System (CMS), such as font, font size, or colour contrast.

Research aims and scope

The specific research questions for this project were:

  • How do web publishers learn about digital content accessibility?
  • What do web publishers know about digital content accessibility?
  • How do web publishers implement digital accessibility requirements and principles in their content?
  • What challenges do web publishers face in creating digitally accessible content?

More comprehensively, I was investigating the accessibility of:

  • Heading levels
    • Ensuring that heading levels are used correctly
    • Not using heading levels for emphasis
  • Links
    • Clear and concise link text which describes the linked destination
    • Link text which makes sense on its own
    • Avoiding URLs on web pages
  • Lists
  • Alt text
    • Clear link text that describes the image
  • Images
    • Ensuring that all images have appropriate alt text
    • Avoiding images of text
  • Videos
    • Including human-corrected captions with any videos uploaded to web pages
    • Making sure that transcripts are available for all videos uploaded to web pages
  • Italic, bold, and underlined text

For more detailed guidance on these topics, please refer to the University of Edinburgh editorial style guide.

Editorial style guide | Information Services

This research has been necessary for the User Experience team as it allows us to identify which areas of content accessibility are challenging for web publishers. From this, the team can adapt guidance and training to provide extra support on these more challenging areas where possible.

Research methods

Interviews with web publishers

I started my research by setting up short, informal interviews with six University web publishers. In these interviews, I asked the publishers about their experiences of creating digitally accessible content. The aim of these conversations was to understand how publishers learned about digital accessibility and what challenges they face when making content as accessible as it can be. During the interviews, we referred to web pages that these publishers work on to get concrete examples that illustrate the topics we discussed. Through these interviews, I was able to identify a number of trends, particularly in the challenges that the interviewees and their colleagues face.

Survey of EdWeb 2 publishers and the Web Accessibility Special Interest Group

Following these interviews, I created a survey to further investigate the findings and collate more supporting evidence for these findings. The survey consisted of 10 questions, three of which were demographic based as a filter, with a final question asking permission to follow up with those who responded.

The other six questions asked about:

  • which actions the participants took to make their content digitally accessible
  • what resources they used to do so
  • what challenges they face in doing so

The findings from the survey were effective in making the information gathered in interviews more robust and provided further evidence for some trends that were identified previously.

To publicise this survey, I sent a brief statement explaining my research into two Teams channels, the Web Accessibility Special Interest Group and the EdWeb 2 Community. Overall, the survey received five responses, and while this is a limited number, I found that it helped to support the findings from the interviews.

Analysis of Effective Digital Content workbooks

The final method of research that I used to learn about the digital accessibility of content on University web pages was by looking at pages that were submitted within Effective Digital Content workbooks as part of the course. The course requires learners to choose pages from a University website and assess the effectiveness of the content. By looking at the pages that learners selected, I was able to use active examples and make note of content accessibility issues that were present on live pages. This process also highlighted a number of trends.

This method of research was also useful in that it provided two separate sources of data. Firstly, the answers in the workbook helped me to gauge learners’ understanding of the principles covered in the course. Secondly, the web pages linked by those taking the course allowed me to have live examples of content to assess against content accessibility principles. While there was not necessarily overlap between the answers in the workbook and the pages submitted as part of the workbook (as some people may not have been fully or at all responsible for the content on those pages, or the content could have been updated since the workbook was submitted), it was useful to see these things separately.

Findings about accessibility

Combining findings from all areas of research for this project, I have identified a number of trends in the accessibility of digital content.

Headings, alt text, and links are the principles most often put into practice by participants

In the interviews and the survey, participants were asked what principles of accessible digital content they actively used when designing content. More than half of participants mentioned three principles in particular, with all participants mentioning at least two, which were:

  • using the correct heading levels
  • adding meaningful alt text to an image
  • writing clear and descriptive link text

Interestingly, while these principles were mentioned frequently by participants, and evidenced by the websites that we discussed in interviews, they are also principles that are often missed on University web pages. This is discussed in more detail in the corresponding sections further on in this post.

PDFs are hard to avoid

One standout finding from the interviews was that web publishers sometimes struggle to find an effective alternative to PDFs. While PDFs are not necessarily accessible, they do have benefits which make them useful for publishers. For example, they are downloadable, searchable, and cannot be easily edited without permission from the owner. There are ways to make PDFs more accessible, such as avoiding decorative images, adhering to accessible content design principles within the PDF, and checking colour contrast. However, the interviewees were more in favour of finding a way to turn their content into a webpage as this is more likely to result in accessible content.

Out of the survey responses, three also mentioned that they had recently chosen to publish content as a web page rather than as a PDF, highlighting their knowledge that a web page is preferable in terms of accessibility. However, their personal preferences or how difficult they found this is unknown as I was unable to follow up with these participants.

Heading levels are often skipped and headings vague

Across web pages that I assessed for correct heading levels, there were several which skipped heading levels throughout the page content, such as going straight to a heading 3 without that heading being nested within a heading 2 section. Additionally, headings on the University web pages that I investigated were often generic, instead of being specific about what a page or section will contain, which is the recommended approach.

The fact that the web publishers who were interviewed and surveyed were aware of the importance of correct headings levels and specific headings, and that the majority of these publishers have attended a staff training or used the editorial style guide, suggests that the guidance provided is accurate and useful for publishers.

To increase the use of correct heading levels, as well as clear and descriptive headings on web pages, participant responses suggest that increasing the reach and engagement of existing training and resources involving headings would be effective. This includes training provided by the User Experience Service, such as Effective Digital Content or Content Improvement Club, and the University of Edinburgh editorial style guide.

Alt text is well written but sometimes missed

In three of the interviews, and in two survey responses, participants mentioned that they struggled to find the time to add alt text to images on their web pages. However, participants in the interviews also stated that they understood the importance of alt text, and what writing meaningful and clear alt text involves. This is reflected in the answers in Effective Digital Content workbooks. The course contains a question asking learners to write meaningful alt text for two images, and this question is often answered well. This suggests that web publishers understand how to write alt text, and that the obstacle in doing so is more likely to be related to time and resource.

One way that time constraints on adding alt text could be improved is to reduce the number of images on a web page, which will not only make this task more manageable but also is also more sustainable.

Explaining acronyms and abbreviations is common

All five responses to the survey stated that they had explained an acronym or abbreviation recently. Although this did not come up in the interviews often – only once – the survey responses suggest that this is common practice for web publishers who are familiar with digital accessibility principles.

Link text is frequently inline or not descriptive

Participants stated that they understand the importance of clear link text as a principle and make effort to implement this into their content. However, similar to headings, this sentiment is not reflected across numerous University web pages. In some of the pages submitted as part of the Effective Digital Content workbooks that I investigated, there were frequent occurrences of inline link text, or link text that does not clearly describe the linked destination.

To increase the writing of link text on a separate line, as well as clear and descriptive link text, participant responses suggest that increasing the reach and engagement of existing training and resources involving links would be effective. This includes training provided by the User Experience Service, such as Effective Digital Content or Content Improvement Club, and the University of Edinburgh editorial style guide.

Findings about staff experience and engagement

A trend from both the interviews and survey responses is that for many of the people involved with this research, their knowledge of digital accessibility started with a personal interest. Specific examples of this that participants mentioned include learning about accessibility as a student (and then going on to be an accessibility advocate for a student society) and working with disabled students and learning through experience.

During the interviews, multiple staff members mentioned that they believe, through their experiences, that a large part of issues with creating accessible digital content at the University surrounds communication. A combination of factors was discussed that had communication at the centre, including:

  • the importance of digital accessibility not being widespread enough.
  • consistency about expectations between schools or areas of the University, such as one page being edited by multiple schools or areas and having different standards.

Job-based constraints were also mentioned frequently, such as limited time to add alt text to all images on a web page and working on a page where the lead publisher takes a design forward approach which can sometimes clash with accessible content principles. These answers were also reflected in the survey responses, with all of the responses mentioning either one or both of these problems.

What resources do web publishers use for learning about and developing their digital accessibility skills?

The primary resource that participants mentioned using to learn about digital accessibility and develop their skills was University-provided staff training, with 10 of 11 participants mentioning this. Effective Digital Content was specifically mentioned twice, and Content Improvement Club three times. In the interviews, two participants mentioned more general staff training, with one survey response saying the same. In the survey responses, three participants also said that they used training provided by the Disability Information Team.

The Web Content Accessibility Guidelines 2.2 (WCAG) is another resource that was frequently mentioned by participants, with six in total saying that this is a resource that they use as guidance on accessibility.

The University of Edinburgh editorial style guide was mentioned by five participants as a resource that they used to provide guidance on digital accessibility, in which the guidance reflects what publishers learn in training courses, meaning that information they take from the style guide is in line with accessibility and content design training.

What I learned from researching content accessibility approaches in EdWeb

I learned a lot during my time researching how web publishers at the University of Edinburgh approach creating accessible digital content. I thoroughly enjoyed the opportunity to work with staff from a variety of different areas of the University. This helped me to learn how to identify commonalities in interview and survey responses despite the areas of work being distinct. I also enjoyed this because I was able to learn much more about the work that goes on across the University and what the work of other teams involved.

I also particularly enjoyed the format of my internship being a combination of individual work and working with other members of my team and the Disability Information team. This balance allowed me to set my own goals while still getting the opportunity to work and learn collaboratively as part of a team, prioritising my tasks between my own and those that I was working on with others.

A limitation of my work was that it was much easier to contact and work with staff who have a genuine interest in the subject area of accessibility, which does not lead to research that is representative of how University staff approach digital accessibility as a whole. Having done the research that I have so far, a continuation of the research would be most beneficial if it focused on the experiences and approaches of staff who are less familiar with digital accessibility requirements and principles, as this would create a more well-rounded understanding of web publisher accessibility approaches at the content level.

Furthermore, another limitation of the work was the time constraints which have restricted my ability to develop solutions to issues identified during the research period. This was expected to a degree, as the solutions depended on the outcomes of the research, which has taken the majority of the 12-week period. The positive outcome of this is that the research and findings will provide the User Experience service with information that allows for both further research and for adaptations to guidance and training if it is deemed necessary.

Conclusion

This research has helped the User Experience Service to assess their training and the resources that are available for publishers to learn more about digital content accessibility. Keeping in touch with the publishing community through projects like this helps the team to direct their effort to real challenges that publishers face on a day to day basis.

The research completed throughout the duration of this project will be supported and advanced by further investigation, particularly by communicating with web publishers who are less involved with digital accessibility as a whole. This will likely help in providing more concrete solutions to digital content accessibility issues across EdWeb 2 pages.

Could ADHD Medications Treat Coexisting Depression and Anxiety? New Studies Say Yes.

26 August 2026 at 21:23

August 26, 2026

ADHD medications decrease antidepressant usage and reduce symptoms of depression and anxiety in people diagnosed with attention deficit, suggest findings from three new studies.

Antidepressant and psychotropic medication use in adults often precedes an ADHD diagnosis; however, a new landmark study published in Acta Psychiatrica Scandinavica152 found that use of selective serotonin reuptake inhibitors (SSRIs) and other antidepressants decreased substantially after adults received an ADHD diagnosis and began treatment with a stimulant or non-stimulant medication.1

Women received antidepressant prescriptions prior to an ADHD diagnosis much more often than did men, according to the Finnish cohort study of 322,416 adults (66,146 with ADHD and 256,270 without). The researchers attribute this to clinicians misinterpreting or misdiagnosing ADHD symptoms as anxiety or depression in women. Depression and anxiety can also result from living with untreated ADHD. As many as 80% of adults with ADHD have at least one coexisting psychiatric disorder; the most common are generalized anxiety, social anxiety, and depression. 2

“ADHD is often associated with coexisting psychiatric conditions,” the researchers wrote. “Differential diagnosis between other conditions and ADHD is not always clear, and patients are sometimes initially treated for another disorder instead.”

Findings from the study support this: At the second-year follow-up, the use of SSRIs, benzodiazepine derivatives, diazepines, oxazepines, thiazepines and oxepines, and other antidepressants decreased in the ADHD cohort. However, SSRI and other antidepressant usage increased in the non-ADHD group during the same period.

Following an ADHD diagnosis, most patients were motivated to try ADHD medication: 95% of patients filled the prescribed medication; 80% of those bought the medication within 10 days. More than half of patients (56.5%) purchased extended-release methylphenidate (brand name: Ritalin).

Just one quarter of late-diagnosed adult patients with ADHD maintained continuous ADHD medication for five years or more.

“This indicates that ADHD drugs were not massively misused, as large purchases would be indicative of [abuse],” the researchers said. “Discontinuation may stem from symptom alleviation, adverse effects, or refinement of diagnoses.”

The study, which analyzed data from Finnish national registers between 2015 and 2020, also found that children and adolescents diagnosed later with ADHD used more antibiotics and anti-inflammatory drugs than did matched controls. After the children began ADHD treatment, the use of these drugs decreased more than it did in controls.

The researchers wrote that “future research is needed, for example, about possible anti-inflammatory effectiveness of ADHD medications, like that of selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors.”

While the Finnish study broadly evaluated how an ADHD diagnosis and subsequent treatment influences antidepressant usage, two new clinical trials took a deeper look into whether a single-medication approach could treat ADHD and co-occurring depression and/or anxiety.

Stimulant Treatment for Co-Occurring Anxiety

During an 8-week Phase 3b clinical trial, centanafadine (brand name: Simtriyo), a first-in-class norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) and central nervous system (CNS) stimulant, delivered statistically significant, clinically relevant improvements in both ADHD and anxiety symptoms.3 Centanafadine received FDA approval for the treatment of ADHD in adults and pediatric patients aged 6 years and older on July 24, 2026.

The trial included 315 adults, aged 18 to 65 years, with ADHD and coexisting generalized or social anxiety disorder. Study participants received either centanafadine XR 280mg or placebo once daily. The study analyzed symptom improvements using the Adult Investigator Symptom Rating Scale (AISRS) and the Hamilton Anxiety Rating Scale (HAM-A).

Non-Stimulant Treatment for Coexisting Depression and Anxiety

Another recent clinical trial published in The Journal of Clinical Psychiatry that adults with ADHD and coexisting depression and/or anxiety symptoms experienced substantial improvement in all three conditions while taking the non-stimulant viloxazine ER (brand name: Qelbree) extended-release capsules alone or in addition to existing treatments.4

During the open-label Phase 4 trial, 150 participants received 200mg of viloxazine ER once daily, with doses increasing up to 600mg. At week 14, the AISRS results showed improved ADHD symptoms and a significant reduction in total baseline AISRS scores. Depression and anxiety rating scales also showed significant improvement in symptoms from baseline to week 14: 71.8% of participants achieved a 30% reduction in AISRS total score, and half of the participants reduced their AISRS total score by 45.6%.

This was the first clinical trial of viloxazine ER in adults with ADHD to include participants with coexisting depression and/or anxiety and to allow concurrent medication use. In addition to viloxazine ER,

  • 28.6% of participants used stimulant medications
  • 44.7% of participants used antidepressants
  • 14.9% of participants used anxiolytic and/or hypnotic medications

Viloxazine ER is an FDA-approved non-stimulant medication for children, ages 6 years or older, and adults with ADHD. 5 It is not approved as an antidepressant in the U.S. However, studies from the 1970s found viloxazine demonstrated antidepressant effects 6 In Europe, viloxazine was approved and used as an immediate-release drug for depression for approximately 30 years before being discontinued for commercial reasons unrelated to efficacy or safety. 7

Clinical Implications

More research is needed to determine whether ADHD medications effectively treat coexisting depression and/or anxiety or if symptom reduction is related to improvements in ADHD symptoms. However, one consistent takeaway from all these studies is the utility of ADHD medications.

The potential benefits of using one medication to treat both ADHD and coexisting depression and/or anxiety could improve safety and medication adherence issues for patients who already have executive function deficits.

“Simultaneous treatment of ADHD and depression and/or anxiety symptoms can be challenging, partly due to safety concerns about combining medications,” the authors of The Journal of Clinical Psychiatry article wrote.

Fewer prescription medications could also translate to greater cost savings for patients.

The steep out-of-pocket costs of ADHD care today — on average, more than $8,500 per child and $4,700 per adult annually — are driving families to ration medication, delay or skip medical appointments, and forgo interventions they rely on to function well, according to ADDitude’s Cost of ADHD Diagnosis & Treatment survey. Of the 1,970 survey respondents, 10% said their ADHD care costs exceeded 10% of their income.

“I just go without medication when I run short of money,” a respondent said.

“I never take my clinician-recommended dosage because I can’t afford it,” another survey respondent said.

“We are paying out-of-pocket for medication, so our kids don’t take it on weekends or vacations,” another mother commented.

“As with any treatment, the best approach to treating depression and/or anxiety and ADHD depends on the patient’s individual needs,” says Roberto Olivardia, Ph.D., who recommends clinicians consider both psychological and psychopharmacological treatments when treating patients with ADHD and coexisting anxiety and/or depression.

“Dealing with ADHD symptoms is challenging enough,” Olivardia says. “Dealing with depression or anxiety, too, is debilitating. Only with proper assessment and diagnosis can treatment for both, or either, be possible.”

Sources

1Westman, E., Prami, T., Kallio, A. et al. (2025). Use of antidepressants decreased after initiation of ADHD treatment in adults — a Finnish nationwide register study describing use of ADHD and non-ADHD medication in people with and without ADHD. Acta Psychiatrica Scandinavica152. https://doi.org/10.1111/acps.70007

2Katzman, M.A., Bilkey, T.S., Chokka, P.R., Fallu, A., & Klassen, L.J. (2017). Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry. https://doi.org/10.1186/s12888-017-1463-3

3P3b short-term study of CTN in patients with ADHD and comorbid anxiety. ClinicalTrials.gov. May 6, 2026. Accessed July 1, 2026. https://clinicaltrials.gov/study/NCT06973577

4Adler, L.A., Lieberman, V.R., Brijbasi, L., Mattingly, G.W., et al. (2026). Viloxazine extended release in adults with attention-deficit/hyperactivity disorder and depression and/or anxiety symptoms: results from a decentralized, open-label, phase 4 trial. J Clin Psychiatry. https://doi.org/10.4088/JCP.25m16234

5Qelbree (viloxazine extended-release capsules). Prescribing information. In: Supernus Pharmaceuticals. Inc.; 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211964s013lbl.pdf

6Greenwood D. (1975). Animal pharmacology of viloxazine (Vivalan). J Int Med Res.

7Findling, R.L., Candler, S.A., Nasser, A.F., et al. (2021). Viloxazine in the management of CNS disorders: a historical overview and current status. CNS Drugs. https://doi.org/10.1007/s40263-021-00825-w

Connective Tissue Disorders Far More Likely Among Neurodivergent: New Study

24 August 2026 at 22:32

August 25, 2026

A neurodivergent individual is 4.3 times more likely to have a structural connective tissue disorder, and 3.4 times more likely to have a hypermobility spectrum disorder than their neurotypical peers, according to a new analysis.1 Analyzing information about 117 million U.S. adults and adolescents, the researchers built on previous data from small trials that found a link between ADHD, autism spectrum disorder (ASD), and connective tissue disorders.2, 3

📺 Free Webinar Aug 25
How Gut Health Impacts ADHD Symptoms: New Insights on Food, Microbes, and Inflammation

Register Now →

Researchers grouped patients into three categories according to neurodevelopmental diagnosis (patients with ASD alone, ADHD alone, and both ASD and ADHD) and matched each patient with a neurotypical control of similar age, sex, and health care visit frequency. Then they explored rates of the following connective tissue disorders:

  • Heritable structural disorders, such as Ehlers-Danlos and Marfan syndrome
  • Hypermobility spectrum disorders
  • Autoimmune and inflammatory disorders, such as lupus

All connective tissue disorders were significantly more prevalent in all categories of neurodivergent patients than they were in comparison patients, with the highest associations found in patients who had ASD and ADHD. Specifically:

Increased likelihood of having… ASD + ADHD ASD Only ADHD Only
…heritable structural connective tissue disorders 438% 340% 93%
…hypermobility spectrum disorders 311% 203% 44%
…autoimmune and inflammatory connective tissue disorders 170% 148% 41%

While the increase in relative risk was dramatic, the incidence of absolute risk for connective tissue disorders among neurotypical as well as neurodivergent groups remained low. Heritable structural disorders, for example, were found in 21 out of 1,000 patients with ADHD and ASD, compared with 4 out of 1,000 neurotypical patients.

Understanding Complex Connections Leads to Better Treatment, Readers Say

Joint hypermobility is central to understanding ADHD’s connections with asthma, allergies, autoimmune disorders, and gut issues, said James Kustow, Ph.D., in his ADDitude article “ADHD’s Curious Connections to Chronic Inflammation and Dysautonomia.”

“Strikingly, about half of people with ADHD are hypermobile,” Kustow wrote. “While many experience no issues, some develop hypermobile Ehlers-Danlos syndrome (hEDS) or Hypermobility Spectrum Disorder (HSD), which are strongly linked to inflammation, in the form of mast cell activation syndrome, and dysautonomia.”

Leading researcher Jessica Eccles, Ph.D., echoed this observation in a recent ADDitude webinar, “How Joint Hypermobility Links Neurodivergence, Chronic Pain, Inflammatory Disorders, and Anxiety,” explaining that hypermobility may be the common thread binding neurodivergence to a range of physical health problems, including anxiety, chronic pain, and fatigue.

“Understanding the interconnectedness of these seemingly disparate symptoms and problems can be transformative, particularly for people seeking a diagnosis and treatment,” Eccles wrote in the ADDitude article “Bendy Bodies, ADHD Brains: Connecting the Dots.”

This understanding, however, is still nascent. Many healthcare providers are not yet familiar with these associations between connective tissue disorders and ADHD, making it difficult for patients to optimize their treatment.

“The traditional healthcare system can be frustrating to navigate with these types of issues, especially for aging women as hormones change, impacting joint health, gut health, and inflammation,” said Jennifer, an ADDitude reader in Utah with joint hypermobility and inflammatory symptoms. “It’s taken me years of frustration, persistence, and exploration to self-solve some of this.”

“It took more than 10 years to find doctors who believed me and helped me pursue a diagnosis of joint hypermobility,” said an ADDitude reader in Canada. “My doctor is an internal medicine specialist who tries to be helpful, even with limited experience, and encourages me to try treatments like compression wear and strength training.”

 Sources

1Bartelt K, Keane G, Franklin B, Higgs E. Neurodivergence Linked to Higher Rates of Connective Tissue Disorders. Epic Research. https://epicresearch.org/articles/neurodivergence-linked-to-higher-rates-of-connective-tissue-disorders. Accessed on August 21, 2026.

2Csecs JLL, Iodice V, Rae CL, et al. Joint hypermobility links neurodivergence to dysautonomia and pain. Front Psychiatry. 2022;12:786916. doi:10.3389/fpsyt.2021.786916

3Cederlöf M, Larsson H, Lichtenstein P, Almqvist C, Serlachius E, Ludvigsson JF. Nationwide population-based cohort study of psychiatric disorders in individuals with Ehlers-Danlos syndrome or hypermobility syndrome and their siblings. BMC Psychiatry. 2016;16:207. doi:10.1186/s12888-016-0922-6

 

Centanafadine Receives FDA Approval for the Treatment of ADHD

29 July 2026 at 18:40

July 29, 2026

Centanafadine (brand name: Simtriyo), the first and only norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) and central nervous system (CNS) stimulant has received U.S. Food and Drug Administration (FDA) approval for the treatment of ADHD in adults and pediatric patients aged 6 years and older. The once-daily, extended-release capsule increases the availability of three neurotransmitters involved in ADHD by blocking their reabsorption, according to the drug’s manufacturer, Otsuka.1

The FDA based its approval on the results of four Phase 3 clinical trials that showed centanafadine produced statistically significant and clinically meaningful improvements in ADHD symptoms compared with placebo, as measured by the ADHD Rating Scale–5 (ADHD-RS-5) in children and adolescents and the Adult ADHD Investigator Symptom Rating Scale (AISRS) in adults. Clinical benefits emerged as early as Week One in both pediatric and adult patients.

Simtriyo is expected to become available later this year following scheduling by the U.S. Drug Enforcement Administration (DEA), according to Otsuka.

Results of Phase 3 Clinical Trials

A set of randomized, double-blind, placebo-controlled trials analyzed centanafadine’s efficacy in 480 children and 459 adolescents. Over six weeks, adolescent participants received either high-dose centanafadine (328.8 mg), low-dose centanafadine (164.4 mg), or placebo; children were similarly assigned to a high-dose, low-dose, or placebo group, with doses based on their weight.

About half of the adolescents who received high-dose centanafadine and a third of children in the high-dose centanafadine group demonstrated an 18-point or greater reduction on the ADHD-RS-5 compared with 23% in the placebo group. (Adolescents and children who received low-dose centanafadine did not experience statistically significant improvements.)2, 3

Adults with ADHD also demonstrated statistically significant improvements, according to two randomized trials evaluating sustained-release (SR) centanafadine. A double-blind, placebo-controlled Phase 3 trial involving 859 adults with ADHD between the ages of 18 and 55 randomly assigned participants to high-dose centanafadine (400 mg), low-dose centanafadine (200 mg), or placebo twice daily for six weeks. At the end of the trial, one quarter of adults taking either low- or high-dose centanafadine achieved an 18-point or greater reduction on the AISRS, compared with 15.4% of the placebo group.4

Symptom improvement is sustained with centanafadine, according to a 52-week extension study involving 662 adults. According to the study, AISRS total scores increased up to 57% in adults who used 400 mg centanafadine SR twice daily. The study’s authors concluded that the medication is safe and effective for long-term treatment of adults with ADHD.5

Simtriyo was generally well-tolerated in pediatric and adult patient populations. The most common side effects were rash and decreased appetite in children 6 to 12 years of age; decreased appetite, nausea, rash, headache, and abdominal pain in adolescents 13 to 17 years of age; and headache, decreased appetite, insomnia, nausea, dry mouth, and diarrhea in adults.

Potential Future Uses for Centanafadine

The new ADHD medication shows promise for treating co-occurring conditions, as well. A recent eight-week, Phase 3b randomized, double-blind, placebo-controlled trial involving 315 adults (aged 18 to 65 years) with ADHD and generalized or social anxiety disorder found that taking a 280 mg dose of centanafadine once daily significantly improved symptoms of both conditions compared to placebo.5 Otsuka stated that complete results will be presented at a future scientific meeting.

“Centanafadine is another way to get serotonin and was shown to help anxiety and mood in people with ADHD since it kind of has an SSRI built in,” said Greg Mattingly, M.D., during the ADDitude webinar “The Brain Chemistry of ADHD: Understanding Dopamine, Serotonin & Norepinephrine.”

Sources

1Otsuka receives FDA approval for first-in-class SIMTRIYO® (centanafadine) for the treatment of attention-deficit hyperactivity disorder (ADHD) in adults and pediatric patients aged 6 years and older. Press release. July 24, 2026. Accessed July 24, 2026. https://www.otsuka-us.com/otsuka-shares-fda-review-update-for-centanafadine

2Ward, C.L., Wilens, T.E., Jin, N., et al. (2025). Efficacy and safety of centanafadine for ADHD treatment in children: A randomized clinical trial. Pediatrics Open Science. https://doi.org/10.1542/pedsos.2024-000349

3Ward, C.L., Childress, A.C., Jin, N., et al (2025). Centanafadine for attention-deficit/hyperactivity disorder in adolescents: A randomized clinical trial. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1016/j.jaac.2025.06.023

4Adler, L.A., Madera-McDonough, J., et al. (2022). Efficacy, safety, and tolerability of centanafadine sustained-release tablets in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000001575

5Mattingly, G.W., Turkoglu, O., Chang, D., Ward, C., Skubiak, T., Zhang, Z., Cutler, A.J. (2025). 52-week open-label safety and tolerability study of centanafadine sustained release in adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. https://doi.org/10.1097/JCP.0000000000002020

6P3b short-term study of CTN in patients with ADHD and comorbid anxiety. ClinicalTrials.gov. May 6, 2026. Accessed July 1, 2026. https://clinicaltrials.gov/study/NCT06973577

❌
❌